Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontransmembrane transporter binding

ANK1 ANK2 ANK3 ITPR1 ITPR2 PACS1 USP10 AKAP9 PACS2 LYN

4.78e-0617218510GO:0044325
GeneOntologyMolecularFunctionprotein kinase activity

ANKK1 STK36 PDK1 NTRK2 CDK10 JAK1 STK10 PIK3C3 MAP4K5 TBK1 ROCK1 ATM STK40 MAPK8 LYN POMK EPHA8

4.53e-0560018517GO:0004672
GeneOntologyMolecularFunctionphosphorylation-dependent protein binding

ANK2 ANK3 LYN

8.95e-05101853GO:0140031
GeneOntologyMolecularFunctionATP hydrolysis activity

ABCA13 SMC1A RNF213 CHD9 ATP13A5 CHD4 HELQ MDN1 ACIN1 CHD6 CARNS1 DYNC1H1 VCP

2.49e-0444118513GO:0016887
GeneOntologyMolecularFunctioninositol 1,4,5-trisphosphate-gated calcium channel activity

ITPR1 ITPR2

2.55e-0431852GO:0005220
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

ANKK1 STK36 PDK1 NTRK2 CDK10 JAK1 STK10 PIK3C3 MAP4K5 TBK1 ROCK1 ATM STK40 MAPK8 LYN POMK EPHA8

3.33e-0470918517GO:0016773
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

CHD9 CHD4 HLTF CHD6

3.71e-04371854GO:0140658
GeneOntologyMolecularFunctionmediator complex binding

SMC1A NIPBL

5.06e-0441852GO:0036033
GeneOntologyBiologicalProcessmicrotubule cytoskeleton organization

STK36 ANK3 STAG1 SMC1A CNTRL NUMA1 CDC20B MEI1 HAUS2 DST AKAP9 ARHGEF10 TTC12 CFAP206 ROCK1 CFAP74 MAPK8 DYNC1H1 VCP DEUP1

7.21e-0672018420GO:0000226
GeneOntologyBiologicalProcessorganelle assembly

KNTC1 STK36 NRAP TBC1D30 STAG1 SYNE1 SMC1A CNTRL NUMA1 CDC20B RNF213 HAUS2 CDK10 USP10 MDN1 ARHGEF10 PIK3C3 TTC12 PACS2 CFAP206 CFAP74 ATM TRAPPC14 MAPK8 DYNC1H1 DEUP1

9.82e-06113818426GO:0070925
GeneOntologyBiologicalProcessestablishment of mitotic sister chromatid cohesion

STAG1 SMC1A NIPBL

2.38e-0571843GO:0034087
GeneOntologyCellularComponentmicrotubule organizing center

CEP104 RAPGEF6 GPAA1 TBC1D30 CNTRL NUMA1 EVC CHD4 HAUS2 CDK10 AKAP9 ARHGEF10 CROCC2 TTC12 LRP1 NLRC5 CFAP206 ROCK1 ATM TRAPPC14 DYNC1H1 DEUP1

2.23e-0591918522GO:0005815
HumanPhenoDisinhibition

CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292

1.93e-058077226HP:0000734
HumanPhenoInappropriate behavior

CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292

1.93e-058077226HP:0000719
HumanPhenoAbnormal response to social norms

CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292

1.93e-058077226HP:5200123
HumanPhenoSocial disinhibition

CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292

1.93e-058077226HP:5200029
HumanPhenoPerseverative thought

ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 TBK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP

5.17e-053777216HP:0030223
HumanPhenoAbnormal social development

CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 ITPR1 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292

5.44e-059087227HP:0025732
HumanPhenoDisordered formal thought process

ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 TBK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP

6.89e-053867216HP:0025769
HumanPhenoAbnormally increased volition

CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292

7.24e-058697226HP:5200263
HumanPhenoAbnormal thought pattern

ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 TBK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP

1.19e-044047216HP:5200269
HumanPhenoMotor stereotypy

ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 PACS2 KCNT1 TRAPPC9 PUS7 VCP

1.20e-042807213HP:0000733
HumanPhenoRestricted or repetitive behaviors or interests

ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP

1.47e-043687215HP:0031432
DomainARM-type_fold

CEP104 STK36 STAG1 VEPH1 RICTOR HUWE1 MEI1 CWC22 ITPR1 ITPR2 ARFGEF3 THADA PIK3C3 TTC12 ATM NIPBL EIF3M GPRASP2

8.02e-0933918518IPR016024
DomainKinase-like_dom

ANKK1 STK36 NTRK2 CHD9 CDK10 JAK1 STK10 DST PIK3C3 MAP4K5 TBK1 ROCK1 ATM STK40 MAPK8 LYN POMK EPHA8

7.77e-0654218518IPR011009
DomainTPR

RGPD2 RANBP2 CNOT10 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

4.38e-051291858SM00028
DomainTPR_repeat

RGPD2 RANBP2 CNOT10 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

5.44e-051331858IPR019734
DomainSAM_1

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

5.73e-05681856PF00536
DomainZU5

ANK1 ANK2 ANK3

7.69e-0591853SM00218
DomainPhosphofurin_acidic_CS-1

PACS1 PACS2

9.76e-0521852IPR019381
DomainPacs-1

PACS1 PACS2

9.76e-0521852PF10254
DomainZU5

ANK1 ANK2 ANK3

1.09e-04101853PS51145
DomainAnk_3

ANK1 ANK3 ANKRD27

1.09e-04101853PF13606
DomainZU5

ANK1 ANK2 ANK3

1.97e-04121853PF00791
DomainZU5_dom

ANK1 ANK2 ANK3

1.97e-04121853IPR000906
Domain-

RGPD2 RANBP2 CNOT10 PSMD11 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

2.27e-0420718591.25.40.10
DomainSAM

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

2.41e-04881856SM00454
DomainSNF2_N

CHD9 CHD4 HLTF CHD6

2.70e-04321854IPR000330
DomainSNF2_N

CHD9 CHD4 HLTF CHD6

2.70e-04321854PF00176
DomainInsP3_rcpt-bd

ITPR1 ITPR2

2.91e-0431852IPR000493
DomainLRR_1

NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6

3.44e-042191859PF00560
DomainSAM_DOMAIN

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

3.65e-04951856PS50105
DomainARM-like

CEP104 STK36 STAG1 RICTOR HUWE1 MEI1 TTC12 NIPBL MED12 GPRASP2

3.72e-0427018510IPR011989
DomainProt_kinase_dom

ANKK1 STK36 NTRK2 CDK10 JAK1 STK10 MAP4K5 TBK1 ROCK1 STK40 MAPK8 LYN POMK EPHA8

3.80e-0448918514IPR000719
DomainLeu-rich_rpt

NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6 NLRP8

3.83e-0427118510IPR001611
DomainSAM

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

4.08e-04971856IPR001660
DomainPROTEIN_KINASE_DOM

ANKK1 STK36 NTRK2 CDK10 JAK1 STK10 MAP4K5 TBK1 ROCK1 STK40 MAPK8 LYN POMK EPHA8

4.13e-0449318514PS50011
DomainTPR-like_helical_dom

RGPD2 RANBP2 CNOT10 PSMD11 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

5.39e-042331859IPR011990
DomainBK_channel_a

KCNU1 KCNT1

5.78e-0441852PF03493
DomainK_chnl_Ca-activ_BK_asu

KCNU1 KCNT1

5.78e-0441852IPR003929
Domain-

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

6.55e-0410618561.10.150.50
DomainPROTEIN_KINASE_ATP

ANKK1 STK36 NTRK2 CDK10 JAK1 STK10 MAP4K5 TBK1 ROCK1 STK40 MAPK8 LYN EPHA8

6.79e-0445918513PS00107
DomainTPR-contain_dom

RGPD2 RANBP2 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

7.47e-041501857IPR013026
DomainSAM/pointed

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

1.10e-031171856IPR013761
DomainTPR_REGION

RGPD2 RANBP2 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

1.30e-031651857PS50293
DomainTPR

RGPD2 RANBP2 TRANK1 TMTC4 IFIT1B TTC12 LONRF3

1.30e-031651857PS50005
Domain-

NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6 NLRP8

1.40e-03321185103.80.10.10
DomainBRK

CHD9 CHD6

1.43e-0361852SM00592
DomainRIH_assoc-dom

ITPR1 ITPR2

1.43e-0361852IPR013662
DomainBRK_domain

CHD9 CHD6

1.43e-0361852IPR006576
DomainIns145_P3_rec

ITPR1 ITPR2

1.43e-0361852PF08709
DomainRIH_assoc

ITPR1 ITPR2

1.43e-0361852PF08454
DomainRIH_dom

ITPR1 ITPR2

1.43e-0361852IPR000699
DomainIns145_P3_rcpt

ITPR1 ITPR2

1.43e-0361852IPR014821
DomainRyanodine_recept-rel

ITPR1 ITPR2

1.43e-0361852IPR015925
Domain-

ITPR1 ITPR2

1.43e-03618521.25.10.30
DomainRYDR_ITPR

ITPR1 ITPR2

1.43e-0361852PF01365
DomainLiprin

PPFIA1 PPFIA3

1.43e-0361852IPR029515
DomainBRK

CHD9 CHD6

1.43e-0361852PF07533
DomainL_dom-like

NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6 NLRP8

1.64e-0332818510IPR032675
DomainChromo_domain

CHD9 CHD4 CHD6

1.66e-03241853IPR023780
DomainPkinase_Tyr

ANKK1 NTRK2 JAK1 LYN POMK EPHA8

1.81e-031291856PF07714
PathwayKEGG_MEDICUS_REFERENCE_COHESIN_LOADING

STAG1 SMC1A NIPBL

7.07e-0591363M47868
PathwayKEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY

ITPR1 ITPR2 LYN

7.07e-0591363M47852
PathwayREACTOME_COHESIN_LOADING_ONTO_CHROMATIN

STAG1 SMC1A NIPBL

1.00e-04101363M27178
PathwayREACTOME_COHESIN_LOADING_ONTO_CHROMATIN

STAG1 SMC1A NIPBL

1.00e-04101363MM14892
PathwayREACTOME_MITOTIC_PROMETAPHASE

KNTC1 RGPD2 RANBP2 STAG1 SMC1A NUMA1 HAUS2 AKAP9 DYNC1H1

1.49e-042021369MM15362
PathwayREACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS

RANBP2 NTRK2 POLR2B CNTRL RNF213 RICTOR PSMD11 SHOC2 AKAP9 MAPK8 LYN MAML3 GOLGA4 VCP

1.56e-0446413614M27547
PathwayREACTOME_MITOTIC_PROMETAPHASE

KNTC1 RANBP2 STAG1 SMC1A CNTRL NUMA1 HAUS2 AKAP9 DYNC1H1

1.60e-042041369M4217
PathwayREACTOME_EICOSANOIDS

CYP4B1 PTGIS CYP4A22

1.81e-04121363M27129
PathwayREACTOME_EICOSANOIDS

CYP4B1 PTGIS CYP4A22

1.81e-04121363MM14845
PathwayREACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS

ANK1 ANK2 ANK3 NRCAM

2.13e-04311364M877
PathwayREACTOME_MITOTIC_TELOPHASE_CYTOKINESIS

STAG1 SMC1A NIPBL

2.34e-04131363MM15363
PathwayREACTOME_MITOTIC_TELOPHASE_CYTOKINESIS

STAG1 SMC1A NIPBL

2.34e-04131363M27661
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

RGPD2 RANBP2 ANK2 ANK3 NRCAM SYNE1 NTRK2 PPFIA1 NUMA1 ADGRB3 ARHGEF12 CHD4 HUWE1 PPFIA3 USP10 DST MDN1 AKAP9 ANAPC1 TBK1 CNKSR3 LRP1 MIOS ROCK1 QSER1 PCDH8 NIPBL KCNT1 DYNC1H1 GOLGA4

8.82e-159631873028671696
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

RANBP2 PSAT1 ANK3 COPA PPFIA1 POLR2B RNF213 RICTOR PSMD11 HUWE1 BCAR1 PPFIA3 SHOC2 ITPR1 ITPR2 PACS1 TRIM11 MED4 AKAP9 TSR1 CASKIN2 MIOS PDP2 ROCK1 HSD17B3 MAPK8 GOLGA4

1.79e-1110491872727880917
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

PSAT1 ANK3 ABHD2 KAT6A EVC RNF213 CHD9 SRSF11 ZSWIM6 HUWE1 BCAR1 RSU1 C2CD2 PKNOX2 ARFGEF3 STK10 PACS1 USP10 THADA PIK3C3 TBK1 XPNPEP3 TTC12 LRP1 NLRC5 CHD6 QSER1 MAML3 EIF3M TRAPPC9 GOLGA4 SOS2

2.17e-1114891873228611215
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

RANBP2 COPA SMC1A POLR2B NUMA1 RNF213 CHD9 CHD4 PPWD1 USP10 LIG3 TRIM11 MED4 MDN1 TSR1 ANAPC1 HLTF ACIN1 ATM QSER1 NIPBL EIF3M MED12 PUS7 VCP ZNF687

4.77e-1110141872632416067
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ANK2 ANK3 NRCAM COPA STAG1 ENPP2 SYNE1 SMC1A ADGRB3 CHD9 CHD4 HUWE1 NR1D1 JAK1 MED4 MAN1A2 DST ARHGEF10 DROSHA MTIF2 LRP1 CHD6 ATM NIPBL GPRASP2 DYNC1H1 VCP ZNF292 SOS2

6.79e-1112851872935914814
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FILIP1 RANBP2 RAPGEF6 COPA SMC1A NUMA1 RICTOR CHD4 HUWE1 NR1D1 STK10 PACS1 USP10 MDN1 ANAPC1 ACIN1 PACS2 ATM MAPK8 NIPBL GOLGA4 ZNF687

2.46e-107741872215302935
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

KNTC1 RANBP2 PSAT1 COPA POLR2B NUMA1 RNF213 SRSF11 CHD4 PSMD11 HUWE1 ITPR1 ITPR2 ARFGEF3 USP10 LIG3 THADA DST MDN1 DIMT1 HLTF ATM TRAPPC14 EIF3M TRAPPC9 DYNC1H1 RBM34 VCP PTCD3

9.46e-1014401872930833792
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

RANBP2 COPA PDK1 SYNE1 SMC1A POLR2B CHD9 SRSF11 CHD4 CWC22 LIG3 DST TSR1 DROSHA XPNPEP3 MIOS ACIN1 CHD6 ATM NIPBL MED12 DYNC1H1 VCP ZNF292 PTCD3

9.93e-1010821872538697112
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

RANBP2 COPA STAG1 SMC1A PPFIA1 SRSF11 CHD4 PSMD11 HUWE1 SHOC2 USP10 MDN1 ANAPC1 HLTF ACIN1 ATM NIPBL DYNC1H1

3.14e-095821871820467437
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

KNTC1 RANBP2 PSAT1 COPA SYNE1 SMC1A POLR2B NUMA1 CHD4 PSMD11 HUWE1 CWC22 USP10 LIG3 THADA MDN1 DIMT1 TSR1 ANAPC1 TBK1 ACIN1 ATM NIPBL EIF3M DYNC1H1 GOLGA4 RBM34 PTCD3

3.27e-0914251872830948266
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

KNTC1 RGPD2 RANBP2 PHF20 COPA STAG1 CNOT10 SYNE1 SMC1A NUMA1 SHOC2 HAUS2 CWC22 ITPR1 PACS1 ZNHIT6 TSR1 ANAPC1 NDUFAF7 ATM NIPBL EIF3M DYNC1H1 VCP PTCD3

3.70e-0911551872520360068
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

ANK1 COPA KAT6A NUMA1 CHD4 HUWE1 BCAR1 LARS2 JAK1 DST ARHGEF10 DYNC1H1 VCP

3.50e-083321871337433992
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

RANBP2 COPA SMC1A NUMA1 RNF213 CHD4 HUWE1 MDN1 TSR1 ANAPC1 ACIN1 NIPBL DYNC1H1

3.50e-083321871332786267
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

RANBP2 ANK1 COPA SMC1A POLR2B NUMA1 SRSF11 CHD4 HUWE1 CWC22 ANKRD27 MDN1 DIMT1 TSR1 HLTF ACIN1 CRYBG1 CHD6 LYN NIPBL EIF3M DYNC1H1 RBM34 ZNF687 PTCD3

4.90e-0813181872530463901
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

RGPD2 RANBP2 RAPGEF6 PPFIA1 CHD4 HUWE1 DST ANAPC1 TBK1 LRP1 CHD6 MED12 GPRASP2 ZNF687

7.16e-084181871434709266
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

RANBP2 COPA SMC1A POLR2B NUMA1 RICTOR CHD4 PSMD11 HUWE1 ANKRD27 LIG3 DST MDN1 DIMT1 MAP4K5 HLTF ACIN1 NIPBL EIF3M MED12 DYNC1H1 GOLGA4 RBM34 VCP PTCD3

8.07e-0813531872529467282
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ANK1 ANK3 PPFIA1 POLR2B NUMA1 CHD9 MEI1 TRANK1 MDN1 CROCC2 ATM MED12 RBM34 ZNF687 ZNF292

9.33e-084971871536774506
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

RAPGEF6 RICTOR SRSF11 CWC22 ANKRD27 ITPR1 PACS1 LIG3 ZNHIT6 DST TSR1 CASKIN2 DROSHA MTIF2 TBK1 HLTF QSER1

9.88e-086501871738777146
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

NRCAM ARHGEF12 CHD9 HUWE1 TRANK1 MDN1 ARHGEF10 DYNC1H1

9.97e-0810418789205841
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

RANBP2 COPA NUMA1 CHD4 HUWE1 DST MDN1 TSR1 ANAPC1 ACIN1 ATM NIPBL MED12 DYNC1H1 RBM34 VCP PTCD3

1.05e-076531871722586326
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

ANK2 ANK3 PDK1 SYNE1 PPFIA1 POLR2B RICTOR RSU1 ITPR1 ITPR2 USP10 THADA MED4 MDN1 AKAP9 ARHGEF10 TSR1 CASKIN2 MAP4K5 MTIF2 ATM GOLGA4 PUS7 RBM34 VCP PTCD3

1.27e-0714871872633957083
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

RANBP2 TBC1D30 CNOT10 SYNE1 PPFIA1 POLR2B ARHGEF12 RICTOR USP10 MED4 MAN1A2 DST MDN1 DIMT1 TSR1 ANAPC1 DROSHA HLTF MIOS CRYBG1 CHD6 NIPBL EIF3M MED12 ZNF687 PTCD3

1.45e-0714971872631527615
Pubmed

Human ankyrins and their contribution to disease biology: An update.

ANK1 ANK2 ANK3

1.53e-073187333410423
Pubmed

Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.

ANK1 ANK2 ANK3

1.53e-073187334289389
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

KNTC1 RAPGEF6 CNOT10 SMC1A PPFIA1 RICTOR RSU1 USP10 DST AKAP9 ANAPC1 TBK1 TRAPPC14 TRAPPC9

1.58e-074461871424255178
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PPFIA1 POLR2B KAT6A RNF213 CHD9 RICTOR CHD4 PPFIA3 JAK1 THADA ZNHIT6 DIMT1 EML5 ANAPC1 DROSHA MTIF2 TBK1 LRP1 LONRF3 VCP ZNF687 PTCD3

1.74e-0711161872231753913
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

COPA SMC1A POLR2B KAT6A NUMA1 CHD4 USP10 LIG3 MED4 MDN1 DIMT1 TSR1 PIK3C3 DROSHA MIOS ACIN1 MED12 RBM34

1.74e-077591871835915203
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

RANBP2 COPA SYNE1 SMC1A POLR2B NUMA1 SRSF11 CHD4 PSMD11 HUWE1 ITPR2 LIG3 DST MDN1 TBK1 XPNPEP3 ACIN1 LYN NIPBL DYNC1H1 VCP

1.77e-0710241872124711643
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

CNOT10 KAT6A PSMD11 JAK1 STK10 THADA ZNHIT6 MDN1 AKAP9 VILL CASKIN2 CROCC2 ROCK1 FGD6 EIF3M RBM34 VCP

2.24e-076891871736543142
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

RANBP2 PSAT1 COPA SMC1A POLR2B NUMA1 CHD9 SRSF11 CHD4 PSMD11 HUWE1 USP10 LIG3 MED4 DIMT1 AKAP9 TSR1 TBK1 ACIN1 LYN MED12 DYNC1H1 VCP

2.88e-0712471872327684187
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

RANBP2 COPA STAG1 ADGRB3 ARHGEF12 SHOC2 ITPR1 USP10 MTIF2 MIOS CHD6 KCNT1 TRAPPC9 VCP

3.37e-074751871431040226
Pubmed

A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.

CEP104 STK36 ABCA13 NUMA1 ARHGEF12 CWC22 STK10 TRIM11 DST MIOS DYNC1H1

4.53e-072841871129459677
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KNTC1 STK36 TBC1D30 SMC1A RNF213 RICTOR TMEM200A THADA KAZN FGD6 MAML3 MED12 TRAPPC9 PUS7

5.26e-074931871415368895
Pubmed

NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.

SMC1A CHD4 MDN1 ANAPC1 HLTF ROCK1 MAML3 TRAPPC9

5.26e-07129187823022380
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

ANK1 TBC1D30 RNF213 HUWE1 PPFIA3 ITPR2 LIG3 CCDC198 DST MDN1 DROSHA TBK1 CHD6 KAZN ATM LYN DYNC1H1

5.61e-077361871729676528
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

GPAA1 COPA PPFIA1 POLR2B NUMA1 SRSF11 PSMD11 LARS2 SHOC2 JAK1 USP10 DST TSR1 PIK3C3 TBK1 FTL MICA LYN NIPBL EIF3M DYNC1H1 RBM34 VCP

5.69e-0712971872333545068
Pubmed

Functional proteomics mapping of a human signaling pathway.

ANK3 STAG1 PSMD11 HUWE1 ANKRD27 MED4 ZNHIT6 MAN1A2 DST DROSHA LRP1 ROCK1 FTL CHD6 DYNC1H1

8.38e-075911871515231748
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

COPA SMC1A POLR2B NUMA1 RNF213 RICTOR CHD4 RSU1 JAK1 USP10 DIMT1 ARHGEF10 TSR1 TBK1 DYNC1H1

1.03e-066011871533658012
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

RAPGEF6 PPFIA1 RICTOR SRSF11 BCAR1 ANKRD27 ARFGEF3 DST MDN1 AKAP9 ARHGEF10 CASKIN2 PIK3C3 CNKSR3 TRAPPC14 FGD6 TRAPPC9 GOLGA4

1.07e-068611871836931259
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

CNOT10 NUMA1 CHD9 CHD4 CWC22 LIG3 MED4 MDN1 ANAPC1 NLRC5 ACIN1 NIPBL DYNC1H1 ZNF687

1.32e-065331871430554943
Pubmed

Defining the membrane proteome of NK cells.

RANBP2 GPAA1 COPA CNOT10 CNTRL RNF213 CHD4 PSMD11 HUWE1 ANKRD27 ITPR1 ITPR2 BPNT2 MED4 MAN1A2 MDN1 PIK3C3 HLTF FTL MED12 DYNC1H1

1.48e-0611681872119946888
Pubmed

BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor.

ITPR1 ITPR2 LYN

1.52e-065187311782428
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

PPFIA1 RNF213 RICTOR ITPR1 ARFGEF3 MDN1 ATM

1.59e-06104187731240132
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

RANBP2 ANK2 ANK3 COPA SMC1A PPFIA1 NUMA1 ARHGEF12 RICTOR DST MAP4K5 ROCK1 MED12 DYNC1H1 GOLGA4 VCP

1.62e-067081871639231216
Pubmed

Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.

ABCA13 ENPP2 NTRK2 PPFIA1 RNF213 ZSWIM6 ITPR1 ARFGEF3 TRANK1 NLRC5 CRYBG1 POMK EIF3M GOLGA4

1.98e-065521871410737800
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

RANBP2 PSAT1 SMC1A NUMA1 CHD4 HUWE1 PPFIA3 DST DROSHA ACIN1 DYNC1H1 VCP PTCD3

2.13e-064771871331300519
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

CNOT10 POLR2B HUWE1 HAUS2 LIG3 MED4 DST TSR1 TBK1 ROCK1 CHD6 EIF3M MED12 ZNF687 PTCD3

2.45e-066451871525281560
Pubmed

In vitro loading of human cohesin on DNA by the human Scc2-Scc4 loader complex.

STAG1 SMC1A NIPBL

3.02e-066187322628566
Pubmed

The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair.

HUWE1 SHOC2 VCP

3.02e-066187334553755
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

RANBP2 NRAP ANK2 SYNE1 SMC1A CHD4 RSU1 DST AKAP9 DROSHA TBK1 LONRF3 VCP

3.33e-064971871323414517
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

NUMA1 SRSF11 PACS1 LIG3 DST MAP4K5 ACIN1 NIPBL DYNC1H1 GOLGA4 PTCD3

4.50e-063601871133111431
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

RANBP2 POLR2B NUMA1 RICTOR CHD4 HUWE1 ITPR1 ITPR2 USP10 ANAPC1 MIOS ZNF687

5.26e-064401871234244565
Pubmed

Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.

ANK1 ANK2 ANK3

5.27e-06718737495297
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

ANK2 COPA PPFIA1 POLR2B ARHGEF12 PSMD11 HUWE1 USP10 MED4 ZNHIT6 DIMT1 TSR1 ANAPC1 LRP1 EIF3M GPRASP2 RBM34 PTCD3

5.72e-069711871833306668
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

STAG1 SMC1A KAT6A NUMA1 CHD9 CHD4 LIG3 TSR1 HLTF CHD6 QSER1 NIPBL RBM34 ZNF292

6.00e-066081871436089195
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CEP104 ADGRB3 SHOC2 CWC22 ANKRD27 USP10 TRANK1 DST TSR1 CASKIN2 CARNS1 KCNT1 ZNF687

6.53e-065291871314621295
Pubmed

TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14.

PSMD11 JAK1 USP10 TRIM11

6.62e-0623187429581427
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

ANK3 PPFIA1 RICTOR JAK1 STK10 PACS1 DST CASKIN2 MAP4K5 ROCK1 LYN

6.96e-063771871138117590
Pubmed

A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.

COPA ANAPC1 ACIN1 DYNC1H1

7.91e-0624187433705438
Pubmed

A potential role for human cohesin in mitotic spindle aster assembly.

STAG1 SMC1A NUMA1

8.40e-068187311590136
Pubmed

Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.

OR5T3 PSAT1 ABHD2 RICTOR HPSE2 RSU1 ITPR1 PKNOX2 PIK3C3 ANAPC1 CARD9 VWA5A NIPBL TRAPPC9 DEUP1 NLRP8

9.43e-068141871623251661
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

CHD4 BCAR1 RSU1 CDK10 ITPR2 JAK1 STK10 CCDC198 DST AKAP9 ANAPC1 MAP4K5 TBK1 MAPK8 LYN EIF3M ZNF687

9.52e-069101871736736316
Pubmed

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

ANK3 SMC1A PPFIA1 ARHGEF12 PSMD11 ARFGEF3 CASKIN2 PIK3C3 TBK1

9.56e-06251187929778605
Pubmed

Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.

COPA PSMD11 ITPR2 AKAP9 MIOS FTL EIF3M

1.09e-05139187725476789
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CEP104 KNTC1 RGPD2 RANBP2 ANK2 COPA STAG1 SYNE1 PPFIA1 CNTRL NUMA1 SRSF11 CHD4 DST MDN1 CNKSR3 ACIN1 CFAP74 CHD6 ATM NIPBL ZNF292

1.13e-0514421872235575683
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

KNTC1 PPFIA1 POLR2B RNF213 HUWE1 ITPR2 ARHGEF10 ANAPC1 MIOS ROCK1 CHD6 QSER1 EIF3M GOLGA4 ZNF687

1.13e-057331871534672954
Pubmed

In vitro nuclear interactome of the HIV-1 Tat protein.

RANBP2 POLR2B NUMA1 RNF213 CHD4 DIMT1 HLTF ACIN1

1.15e-05195187819454010
Pubmed

Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics.

RANBP2 CHD4 HUWE1 LIG3 BPNT2 ANAPC1 ACIN1

1.43e-05145187728846114
Pubmed

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

RGPD2 RANBP2 SALL3 POLR2B CHD4 PSMD11 QSER1

1.50e-05146187723892456
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

CNOT10 SHOC2 CWC22 DST ACIN1 QSER1 NIPBL MED12 RBM34 VCP PTCD3

1.52e-054101871126949251
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

STK36 COPA SYNE1 SMC1A POLR2B CNTRL CHD4 PPFIA3 ITPR1 LIG3 HLTF CHD6 EIF3M DYNC1H1 ZNF687

1.57e-057541871535906200
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

STAG1 SMC1A POLR2B RNF213 ITPR2 JAK1 LIG3 ACIN1 MED12 ZNF687

1.76e-053411871032971831
Pubmed

Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

RGPD2 RANBP2 ANK2 SMC1A NUMA1 SRSF11 CHD4 TSR1 ACIN1

1.76e-05271187932433965
Pubmed

Cell organization, growth, and neural and cardiac development require αII-spectrin.

ANK1 ANK2 ANK3

1.79e-0510187322159418
Pubmed

Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.

ANKK1 RANBP2 STAG1 SMC1A MDN1 ANAPC1 NIPBL MED12 DYNC1H1

1.81e-05272187931010829
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

ANK2 SYNE1 DST AKAP9 GPRASP2 DYNC1H1 GOLGA4

1.87e-05151187717043677
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

RAPGEF6 ANK3 PDK1 PPFIA1 RICTOR STK10 PACS1 DST ARHGEF10 MAP4K5 ROCK1

1.94e-054211871136976175
Pubmed

Systematic identification of factors for provirus silencing in embryonic stem cells.

RGPD2 RANBP2 CHD4 HUWE1 MDN1 TSR1 EIF3M

2.03e-05153187726365490
Pubmed

Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.

TSR1 PDP2 CHD6 CARNS1 FGD6 KCNT1 ZNF687

2.03e-05153187710718198
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

SALL3 NUMA1 CHD4 CWC22 ACIN1 ZNF687

2.07e-05103187632744500
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

STK36 RAPGEF6 ANK3 NUMA1 BCAR1 PKNOX2 STK10 MAP4K5 ATM DYNC1H1 SOS2

2.36e-054301871135044719
Pubmed

Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.

SMC1A CHD4 HUWE1 HELQ ACIN1 ATM NIPBL

2.40e-05157187730686591
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

RAPGEF6 SALL3 ANK3 ABHD2 PPFIA1 POLR2B CNTRL RICTOR HUWE1 ITPR1 PACS1 EML5 VILL TSR1 ACIN1 CRYBG1 ROCK1 QSER1

2.49e-0510841871811544199
Pubmed

The protein interaction landscape of the human CMGC kinase group.

RANBP2 SMC1A POLR2B HUWE1 CDK10 MED4 AKAP9 DROSHA ACIN1 ROCK1 MAPK8 EIF3M MED12 RBM34

2.65e-056951871423602568
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

RANBP2 COPA SMC1A POLR2B NUMA1 CHD4 HUWE1 PPWD1 RSU1 USP10 DIMT1 TSR1 XPNPEP3 HLTF NIPBL EIF3M DYNC1H1 GOLGA4 PUS7 VCP PTCD3

2.71e-0514151872128515276
Pubmed

VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.

CNOT10 POLR2B NUMA1 SRSF11 HUWE1 RSU1 USP10 MDN1 VCP

2.83e-05288187923383273
Pubmed

CHD chromatin remodelling enzymes and the DNA damage response.

CHD4 CHD6

2.88e-052187223954449
Pubmed

A large Canadian cohort provides insights into the genetic architecture of human hair colour.

CDK10 EDNRB

2.88e-052187234737440
Pubmed

Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice.

ITPR1 ITPR2

2.88e-052187215201137
Pubmed

Cholinergic augmentation of insulin release requires ankyrin-B.

ANK2 ITPR1

2.88e-052187220234002
Pubmed

Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B.

ANK2 ITPR1

2.88e-052187214722080
Pubmed

Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2.

ITPR1 ITPR2

2.88e-052187223582047
Pubmed

Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.

CNTNAP3B CNTNAP3

2.88e-052187226807827
Pubmed

NuMA1 promotes axon initial segment assembly through inhibition of endocytosis.

ANK3 NUMA1

2.88e-052187231727776
Pubmed

Targeted ablation of NrCAM or ankyrin-B results in disorganized lens fibers leading to cataract formation.

ANK2 NRCAM

2.88e-052187211449000
Pubmed

Lyn tyrosine kinase promotes silencing of ATM-dependent checkpoint signaling during recovery from DNA double-strand breaks.

ATM LYN

2.88e-052187225173936
Pubmed

VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology.

SHOC2 VCP

2.88e-052187231091164
Pubmed

An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I.

PACS1 PACS2

2.88e-052187222496420
Pubmed

Type 1 and 2 IP3 receptors respond differently to catecholamines and stress.

ITPR1 ITPR2

2.88e-052187219120126
Pubmed

Phenotypes and genotypes in individuals with SMC1A variants.

SMC1A NIPBL

2.88e-052187228548707
InteractionRAPGEF5 interactions

ANK1 ANK2 ANK3 ARHGEF12 RICTOR ARHGEF10 SOS2

1.21e-06601847int:RAPGEF5
InteractionEEF1AKMT3 interactions

KNTC1 CNOT10 SMC1A ARHGEF12 RICTOR HUWE1 NR1D1 ANKRD27 ZNHIT6 MDN1 ARHGEF10 ANAPC1 TBK1 MAPK8 GPAT2

1.34e-0636418415int:EEF1AKMT3
InteractionBMI1 interactions

RANBP2 SYNE1 NUMA1 CHD4 CFAP141 PPWD1 ITPR2 ARFGEF3 DST AKAP9 CASKIN2 DROSHA NLRC5 ACIN1 ATM EIF3M MED12 DYNC1H1 ZNF687 PTCD3

2.72e-0665918420int:BMI1
InteractionHERC2 interactions

CEP104 ANK2 COPA PPFIA1 ARHGEF12 SRSF11 PSMD11 ITPR2 MED4 DST AKAP9 LRRC31 TBK1 MIOS FTL C2CD6 EIF3M

3.89e-0650318417int:HERC2
InteractionUBXN6 interactions

KNTC1 COPA ARHGEF12 RICTOR ZNHIT6 DST MDN1 ARHGEF10 ANAPC1 TXNRD3 MAPK8 GPAT2 VCP

9.58e-0632518413int:UBXN6
InteractionOTUD7A interactions

ANK2 ANK3 ADGRB3 BCAR1 ARFGEF3 VCP

1.46e-05581846int:OTUD7A
InteractionDIRAS3 interactions

ANK3 PPFIA1 RICTOR HUWE1 DST PIK3C3 MAP4K5 MTIF2 LYN GOLGA4 VCP

3.03e-0526218411int:DIRAS3
InteractionCDC5L interactions

STK36 RANBP2 COPA SYNE1 SMC1A PPFIA1 RICTOR CHD4 PSMD11 CFAP141 HUWE1 PPWD1 CWC22 USP10 DST MDN1 AKAP9 ANAPC1 HLTF NIPBL DYNC1H1

3.73e-0585518421int:CDC5L
InteractionFBXO22 interactions

ANK1 ANK3 PPFIA1 POLR2B NUMA1 CHD9 BCAR1 MEI1 TRANK1 MDN1 CROCC2 ATM MED12 RBM34 ZNF687 ZNF292

3.79e-0554018416int:FBXO22
InteractionUSP15 interactions

ANK3 SMC1A KAT6A RNF213 CHD4 PSMD11 HUWE1 USP10 TRIM11 MED4 TSR1 ANAPC1 CARD9 TBK1 DYNC1H1 VCP

4.32e-0554618416int:USP15
InteractionKCNA3 interactions

RANBP2 ANK2 ANK3 COPA ABCA13 NTRK2 SMC1A PPFIA1 NUMA1 ARHGEF12 RNF213 CHD9 RICTOR HELQ DST MAP4K5 ROCK1 MED12 DYNC1H1 GOLGA4 VCP

4.88e-0587118421int:KCNA3
InteractionEED interactions

KNTC1 RANBP2 PSAT1 COPA STAG1 SMC1A POLR2B NUMA1 RICTOR CHD4 PSMD11 HUWE1 PPWD1 CWC22 USP10 LIG3 THADA MAN1A2 DIMT1 VILL DROSHA TBK1 ACIN1 FTL NIPBL EIF3M DYNC1H1 VCP ZNF687

4.98e-05144518429int:EED
InteractionTNIK interactions

ANK2 ANK3 SYNE1 BEX1 NTRK2 HUWE1 USP10 DST AKAP9 LYN PCDH8 DYNC1H1 GOLGA4

5.04e-0538118413int:TNIK
InteractionMEX3A interactions

ANK1 COPA KAT6A NUMA1 CHD4 HUWE1 BCAR1 LARS2 JAK1 DST ARHGEF10 DYNC1H1 VCP

5.46e-0538418413int:MEX3A
InteractionPCNT interactions

SYNE1 CNTRL CHD4 HUWE1 MED4 DST AKAP9 FTL NIPBL DEUP1

7.72e-0524118410int:PCNT
InteractionBRD1 interactions

POLR2B KAT6A NUMA1 RICTOR CHD4 DIMT1 ANAPC1 MTIF2 TBK1 LRP1 QSER1 ZNF687

7.99e-0534418412int:BRD1
InteractionSIGLECL1 interactions

KNTC1 STAG1 RNF213 CWC22 ARFGEF3 THADA TTC12

8.07e-051131847int:SIGLECL1
InteractionHMGN5 interactions

PSAT1 SMC1A POLR2B KAT6A NUMA1 PSMD11 LIG3 NIPBL

8.70e-051541848int:HMGN5
InteractionHECTD1 interactions

COPA SMC1A POLR2B KAT6A NUMA1 CHD4 HUWE1 USP10 LIG3 MED4 MDN1 DIMT1 ARHGEF10 LRRC31 TSR1 PIK3C3 DROSHA MIOS ACIN1 MED12 RBM34 VCP

9.69e-0598418422int:HECTD1
InteractionSUMO2 interactions

RANBP2 COPA SMC1A NUMA1 RNF213 CHD4 HUWE1 DST MDN1 TSR1 ANAPC1 TBK1 ACIN1 NIPBL DYNC1H1 VCP

1.09e-0459118416int:SUMO2
InteractionCCDC8 interactions

RANBP2 COPA NTRK2 SMC1A NUMA1 CHD4 HUWE1 ITPR2 LIG3 DST MDN1 TBK1 LYN NIPBL GPRASP2 DYNC1H1 VCP

1.13e-0465618417int:CCDC8
InteractionH2AX interactions

RANBP2 BEX1 SMC1A NUMA1 CHD4 HUWE1 BCAR1 LIG3 MDN1 HLTF ATM MAPK8 NIPBL VCP ZNF687 PTCD3

1.14e-0459318416int:H2AX
InteractionCTDP1 interactions

PPFIA1 POLR2B RNF213 RICTOR ITPR1 ARFGEF3 MED4 MDN1 ATM

1.24e-042071849int:CTDP1
InteractionNANOG interactions

RANBP2 SALL3 STAG1 POLR2B CHD4 PSMD11 HUWE1 MDN1 AKAP9 TSR1 HLTF QSER1 MED12 PTCD3

1.41e-0448118414int:NANOG
InteractionBANK1 interactions

ITPR1 ITPR2 LYN

1.55e-04121843int:BANK1
InteractionCHL1 interactions

ANK1 ANK2 ANK3

1.55e-04121843int:CHL1
InteractionSIRT7 interactions

RANBP2 COPA NUMA1 CHD4 HUWE1 DST MDN1 TSR1 ANAPC1 ACIN1 FTL ATM NIPBL MED12 DYNC1H1 RBM34 VCP PTCD3

1.66e-0474418418int:SIRT7
InteractionPOLR1G interactions

SMC1A POLR2B KAT6A NUMA1 CHD9 HUWE1 LIG3 MED4 MDN1 TSR1 MTIF2 NIPBL RBM34 ZNF292

1.67e-0448918414int:POLR1G
InteractionPINK1 interactions

RANBP2 PSAT1 SMC1A NUMA1 RICTOR CHD4 PSMD11 HUWE1 PPFIA3 DST DROSHA DHRS9 ACIN1 FTL DYNC1H1 VCP PTCD3

1.70e-0467918417int:PINK1
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

RGPD2 RANBP2 CNOT10 TRANK1 TMTC4 IFIT1B TTC12

1.43e-051151247769
GeneFamilySterile alpha motif domain containing

PPFIA1 PPFIA3 CASKIN2 CNKSR3 KAZN EPHA8

3.16e-05881246760
GeneFamilyInositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits

ITPR1 ITPR2

1.39e-0431242297
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ARHGEF12 ARHGEF10 FGD6 SOS2

1.09e-03661244722
GeneFamilyCohesin complex

STAG1 SMC1A

1.27e-03812421060
GeneFamilyAnkyrin repeat domain containing

ANKK1 ANK1 ANK2 ANK3 ANKRD27 TRANK1 CASKIN2

1.41e-032421247403
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

RANBP2 PHF20 STAG1 PPFIA1 POLR2B KAT6A CHD9 LARS2 SHOC2 C2CD2 ITPR1 TDRD7 STK10 DST MDN1 AKAP9 ARHGEF10 PIK3C3 MAP4K5 MTIF2 HLTF ROCK1 KAZN MAPK8 LYN NIPBL GOLGA4 ZNF292 SOS2

2.51e-1285618529M4500
CoexpressionHALLMARK_MITOTIC_SPINDLE

KNTC1 RAPGEF6 SMC1A CNTRL NUMA1 ARHGEF12 RICTOR BCAR1 DST ROCK1 FGD6 DYNC1H1

1.95e-0819918512M5893
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

RANBP2 RAPGEF6 PHF20 HTR7 SYNE1 POLR2B CNTRL KAT6A NUMA1 RNF213 RICTOR HUWE1 ITPR1 ITPR2 JAK1 STK10 PACS1 TRANK1 MAN1A2 AKAP9 VWA5A CD101 TBK1 NLRC5 CRYBG1 ROCK1 ATM NIPBL DYNC1H1 ZNF292

2.09e-07149218530M40023
CoexpressionGSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP

RAPGEF6 STAG1 PDK1 SYNE1 ARHGEF12 PPWD1 TMTC4 MTIF2 HLTF ATM

7.96e-0718418510M9005
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

STAG1 PPFIA1 KAT6A CHD9 LARS2 C2CD2 TDRD7 DST MDN1 AKAP9 PIK3C3 MAP4K5 LYN GOLGA4 ZNF292

1.23e-0646618515M13522
CoexpressionGSE22886_NAIVE_VS_MEMORY_TCELL_UP

NUMA1 HPSE2 HAUS2 AKAP9 TSR1 ANAPC1 CARD9 ATM ZNF292

1.04e-051941859M4416
CoexpressionGSE11386_NAIVE_VS_MEMORY_BCELL_DN

KCTD19 SYNE1 CHD9 RICTOR MDN1 AKAP9 NLRC5 NIPBL

1.73e-051581858M372
CoexpressionGSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN

PDK1 CNTRL SHOC2 JAK1 VWA5A NLRC5 TRAPPC14 NIPBL

2.47e-051661858M8129
CoexpressionGSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP

RAPGEF6 PSMD11 HUWE1 ZNHIT6 VWA5A MTIF2 EIF3M SOS2

3.46e-051741858M6296
CoexpressionPILON_KLF1_TARGETS_UP

KNTC1 ANK3 EXD1 PPFIA1 HUWE1 BCAR1 SHOC2 ADAM12 C2CD2 EDNRB TBK1 MIOS LGR6

6.37e-0550318513M2226
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

KNTC1 RAPGEF6 ENPP2 PPFIA1 SRSF11 PPWD1 ITPR1 ITPR2 TDRD7 TBK1 HLTF ATM QSER1 NIPBL GOLGA4

6.97e-0565618515M18979
CoexpressionGSE3982_MAST_CELL_VS_BCELL_DN

CNTNAP3B PDK1 SYNE1 SMC1A HAUS2 JAK1 THADA CCDC198

8.30e-051971858M5437
CoexpressionGSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN

ANK1 KAT6A ARHGEF12 HUWE1 RSU1 JAK1 FTL NIPBL

8.90e-051991858M5726
CoexpressionGSE27786_LSK_VS_CD4_TCELL_DN

NRAP RICTOR PKNOX2 JAK1 HLTF NLRC5 ROCK1 ZNF292

9.22e-052001858M4747
CoexpressionGSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP

CNOT10 JAK1 MED4 MAN1A2 TSR1 TXNRD3 FGD6 PTCD3

9.22e-052001858M7172
CoexpressionGSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP

PDK1 SRSF11 CFAP141 CDK10 USP10 EML5 MTIF2 XPNPEP3

9.22e-052001858M4323
CoexpressionSTARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP

CHD9 RICTOR SRSF11 CHD4 SHOC2 BPNT2 ACIN1 ROCK1

1.13e-042061858M2817
CoexpressionSTARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP

CHD9 RICTOR SRSF11 CHD4 SHOC2 BPNT2 ACIN1 ROCK1

1.21e-042081858MM581
CoexpressionPILON_KLF1_TARGETS_UP

KNTC1 ANK3 EXD1 PPFIA1 HUWE1 BCAR1 SHOC2 ADAM12 C2CD2 EDNRB TBK1 MIOS LGR6

1.32e-0454118513MM1061
CoexpressionASTON_MAJOR_DEPRESSIVE_DISORDER_DN

COPA ENPP2 NTRK2 PSMD11 ARHGEF10 ATM MAPK8

1.46e-041601857M11011
CoexpressionZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN

RAPGEF6 JAK1 STK10 NIPBL

1.47e-04381854M1751
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500

SALL3 NRCAM NTRK2 SMC1A ADGRB3 SRSF11 LARS2 CWC22 AKAP9 EML5 MTIF2 ROCK1 CFAP74 FGD6 NIPBL MAML3 GOLGA4

1.70e-0649818417Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

PHF20 SMC1A POLR2B KAT6A ARHGEF12 CHD9 CHD4 LARS2 ZNHIT6 EML5 NDUFAF7 MTIF2 TBK1 CFAP74 MAML3 DYNC1H1 GOLGA4 ZNF292

4.54e-0659518418Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000

FILIP1 ANK2 ANK3 TBC1D30 NRCAM ABHD2 NTRK2 ADGRB3 HUWE1 ADAM12 HAUS2 EDNRB JAK1 LIG3 MAN1A2 AKAP9 ANAPC1 SLITRK6 MAPK8 VCP

2.99e-0581818420gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlasFacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2

RAPGEF6 SMC1A POLR2B KAT6A CHD9 SRSF11 ITPR2 THADA ZNHIT6 MTIF2 TBK1 CFAP74 QSER1 FGD6 MAML3 ZNF292

3.43e-0556418416Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5

SMC1A POLR2B KAT6A ARHGEF12 CHD9 SRSF11 TMEM200A ZNHIT6 AKAP9 NDUFAF7 MTIF2 TBK1 QSER1 NIPBL MAML3 GPRASP2 ZNF292

3.56e-0562918417Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlasalpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1

RAPGEF6 PDK1 RICTOR ITPR2 JAK1 THADA MDN1 EML5 NLRC5 ATM MED12 ZNF292

3.89e-0533618412GSM538413_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3

NTRK2 SMC1A AKAP9 EML5 MTIF2 ROCK1 FGD6 NIPBL GOLGA4

4.70e-051921849Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

PHF20 ANK2 NRCAM SMC1A CNTRL VEPH1 CHD9 SRSF11 CHD4 LARS2 PPWD1 PKNOX2 MDN1 DIMT1 AKAP9 EML5 MTIF2 ROCK1 CFAP74 ATM QSER1 TRAPPC14 MAPK8 NIPBL ZNF292

8.92e-05125718425facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000

RANBP2 SALL3 ANK2 NRCAM NTRK2 ADGRB3 SRSF11 ZSWIM6 LARS2 CWC22 CDK10 EDNRB MDN1 AKAP9 EML5 ROCK1 CHD6 SLITRK6 TRAPPC14 GPRASP2 DEUP1

1.29e-0498318421Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

PHF20 ANK2 NRCAM SMC1A CNTRL VEPH1 CHD9 SRSF11 CHD4 LARS2 PPWD1 CWC22 PKNOX2 MDN1 DIMT1 AKAP9 EML5 MTIF2 ROCK1 CFAP74 ATM QSER1 TRAPPC14 MAPK8 NIPBL DEUP1 ZNF292

1.51e-04145918427facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANK3 SYNE1 RNF213 RICTOR SRSF11 AKAP9 NLRC5 ATM GOLGA4 ZNF292

1.31e-0819918710f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

RNF213 SRSF11 AKAP9 ACIN1 ROCK1 ATM NIPBL DYNC1H1 GOLGA4 ZNF292

1.37e-082001871012f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RANBP2 RAPGEF6 SYNE1 KAT6A RNF213 AKAP9 NLRC5 CRYBG1 ATM

4.76e-0817118792e9a20f8980b78325c52065a9c14ab3656267c05
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK2 COPA ENPP2 NTRK2 SRSF11 DST EML5 GOLGA4 VCP

1.34e-071931879471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK2 COPA ENPP2 NTRK2 SRSF11 DST EML5 GOLGA4 VCP

1.34e-071931879fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK2 COPA ENPP2 SRSF11 HUWE1 DST EML5 GOLGA4 VCP

1.40e-0719418790b023de48ed8a550d169bbe954881eb04bf4f981
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANK3 PDK1 SYNE1 RNF213 SRSF11 AKAP9 ATM GOLGA4 ZNF292

1.60e-07197187957ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

CEP104 ABHD2 CNTRL MAN1A2 AKAP9 MAP4K5 ROCK1 NIPBL GOLGA4

1.74e-07199187961b1ed2db71b96157b92b7535d1955a4033098da
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

CEP104 CNTRL MAN1A2 AKAP9 MAP4K5 ROCK1 NIPBL GOLGA4 ZNF292

1.74e-071991879fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK2 SYNE1 ZSWIM6 EDNRB TMTC4 CARD9 PRELP LGR6

7.87e-0717518781d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK2 SYNE1 ZSWIM6 EDNRB TMTC4 CARD9 PRELP LGR6

7.87e-071751878427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

RANBP2 RAPGEF6 ANK3 RNF213 HUWE1 CRYBG1 ATM RBM34

1.01e-061811878f2315414e714ac86211546a935660c4be6e85f1b
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

COPA RICTOR PPWD1 ITPR2 DST AKAP9 ROCK1 ATM

1.30e-0618718780099def970fbc828756fbf853eca2ce77b8cd342
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 BEX1 ADAM12 GPR162 ITPR1 ARFGEF3 KCNT1 EPHA8

1.40e-061891878f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

RGPD2 RANBP2 PHF20 RICTOR SRSF11 CRYBG1 GOLGA4 ZNF292

1.52e-0619118781ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

ENPP2 RICTOR ITPR2 AKAP9 CHD6 NIPBL GOLGA4 ZNF292

1.58e-061921878916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANK3 PDK1 SYNE1 RNF213 SRSF11 AKAP9 ATM ZNF292

1.64e-0619318789337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

RAPGEF6 SYNE1 CNTNAP3 RNF213 AKAP9 NLRC5 GOLGA4

1.69e-061351877ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCellfacs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KAT6A CHD9 JAK1 MAN1A2 DST LRP1 LONRF3 MAML3

1.77e-061951878a1478021a3ed0e779716393124ca2a7770c433b7
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANK3 PDK1 SYNE1 RNF213 NLRC5 PDP2 ATM ZNF292

1.91e-061971878e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCellhealthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

ABHD2 SYNE1 ARHGEF12 RNF213 JAK1 STK10 ATM LGR6

1.99e-061981878d7053a898e04478c577381085f615edaad3cdc5b
ToppCellfacs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COPA POLR2B ARHGEF12 HUWE1 SHOC2 DST MAP4K5 VCP

1.99e-0619818782f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCellCOVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

NRCAM ADGRB3 ADAM12 TMEM200A PKNOX2 DST PRELP LRP1

1.99e-0619818783ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

ANK2 NRCAM ADGRB3 ADAM12 PKNOX2 DST PRELP KAZN

1.99e-061981878df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellhealthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass

ABHD2 SYNE1 ARHGEF12 RNF213 JAK1 STK10 ATM LGR6

1.99e-061981878aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCellfacs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COPA POLR2B ARHGEF12 HUWE1 SHOC2 DST MAP4K5 VCP

1.99e-061981878f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

ANK2 BEX1 CHD9 SRSF11 ZSWIM6 AKAP9 MAPK8 ZNF292

1.99e-061981878de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

ANK3 STAG1 ADGRB3 ZSWIM6 ITPR2 PACS1 MAML3 TRAPPC9

2.06e-06199187894b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

MAN1A2 DST AKAP9 MAP4K5 ROCK1 NIPBL GOLGA4 ZNF292

2.06e-061991878c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellLPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

KAT6A ARHGEF12 RNF213 EDNRB DST ARHGEF10 CASKIN2 DYNC1H1

2.14e-06200187879e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

RANBP2 RAPGEF6 ANK3 RNF213 RICTOR CRYBG1 ATM

4.42e-0615618771545169694f686d28648a68b552c2ae606599d66
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type.

ANK3 BEX1 AKAP9 DYNC1H1 RBM34

4.91e-0659187574590437b1d9a2a8fe56d79b2e66803528b81298
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

RANBP2 RAPGEF6 ANK3 KAT6A ITPR1 CRYBG1 ATM

5.67e-061621877b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCelldroplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBC1D30 HTR7 ABHD2 ADAM12 SYCE1L KAZN LGR6

6.92e-061671877a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 PCDH8

8.72e-06173187761907116a1460bc157ba73b5edd108db7dd5de4b
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 EPHA8

9.39e-06175187711f49f00e000cbc137e3540a6d6805cde21d96e6
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 PCDH8

9.75e-0617618774843af68f013732c28a8b8edad30d5fa0f2b084b
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 PCDH8

9.75e-06176187795d5a4fdff1b9c715636684d22e06f8727ac0e7a
ToppCellfacs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CYP4B1 ENPP2 ASL PDP2 FTL GPAT2

1.01e-0517718779c7c6824b9011363851f084a500d665f025b026e
ToppCellfacs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 CYP4B1 ENPP2 ASL PDP2 FTL GPAT2

1.01e-0517718772bf639e9e801e5144462ffc957f5739e0dfcd500
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

SYNE1 NUMA1 RICTOR DST MDN1 CASKIN2 DYNC1H1

1.01e-051771877e8ab340b20cd41554c3841fe980e078e878af35f
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 RANBP2 STAG1 SYNE1 SMC1A CNTRL AKAP9

1.05e-05178187701dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 PCDH8

1.09e-0517918773b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 PCDH8

1.17e-0518118777704f236831cffe4f2a75d4c461eb88b4177e206
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

SYNE1 KAT6A RNF213 AKAP9 NLRC5 ATM

1.23e-05121187619333a660800b583fa27b495c1f7828e6636a257
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

RNF213 CHD9 TRANK1 DST NLRC5 FGD6 ZNF292

1.26e-0518318778f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

RAPGEF6 NRCAM RICTOR NLRC5 CFAP74 ATM

1.35e-051231876511b7c20a4a85e49980936d52af7dbca19bb848e
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

KNTC1 RNF213 HUWE1 TMEM200A ITPR2 PDP2 ZNF292

1.40e-0518618778571956890fc9894d766ba294a28e376b4aba428
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

RANBP2 RNF213 RICTOR HUWE1 ITPR1 NIPBL DYNC1H1

1.50e-051881877ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FILIP1 ANK3 NRCAM HTR7 HPSE2 PPWD1 TDRD7

1.50e-0518818776468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FILIP1 ANK3 NRCAM HTR7 HPSE2 PPWD1 TDRD7

1.50e-0518818777a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FILIP1 ANK3 NRCAM HTR7 HPSE2 PPWD1 TDRD7

1.50e-0518818779cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCellILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MAN1A2 AKAP9 CRYBG1 CHD6 ATM GOLGA4 ZNF292

1.55e-051891877a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

FILIP1 NRAP ANK2 ANK3 ABHD2 ARHGEF12 CNKSR3

1.55e-0518918770a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

FILIP1 NRAP ANK2 ANK3 ABHD2 ARHGEF12 CNKSR3

1.60e-05190187793c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KAT6A ARHGEF12 CHD4 JAK1 DST AKAP9 GOLGA4

1.60e-051901877d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HPSE2 PTGIS ITPR1 PKNOX2 DST EML5 LRP1

1.66e-051911877c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HPSE2 PTGIS EDNRB ITPR1 PKNOX2 DST LRP1

1.66e-051911877806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 ENPP2 ABHD2 NTRK2 ADAM12 DST SLITRK6

1.66e-051911877f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HPSE2 PTGIS ITPR1 PKNOX2 DST EML5 LRP1

1.66e-051911877cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 ENPP2 ABHD2 NTRK2 ADAM12 DST SLITRK6

1.71e-0519218775b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RANBP2 RAPGEF6 ANK3 RNF213 SRSF11 CRYBG1 ATM

1.71e-05192187747646d7e4990be85072987f92bf18d52f8da752e
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

CHD9 CHD4 SHOC2 ITPR1 ARHGEF10 LYN VCP

1.77e-05193187708696a99309f5b088692ddac8cca35413b5e810d
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

RANBP2 SMC1A HUWE1 ARFGEF3 AKAP9 POMK DYNC1H1

1.77e-051931877abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NTRK2 KAT6A ARHGEF12 EDNRB ARHGEF10 CASKIN2 NLRC5

1.77e-051931877a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

RICTOR ITPR2 AKAP9 CHD6 NIPBL GOLGA4 ZNF292

1.77e-051931877e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCelldroplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COPA ENPP2 SRSF11 DST EML5 GOLGA4 VCP

1.83e-0519418773a3ecedcdc7691cf21775818b598208fcb980c29
ToppCellCOVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type

ADGRB3 ADAM12 PTGIS PKNOX2 PRELP LRP1 KAZN

1.83e-051941877d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

FILIP1 NRAP ANK2 ANK3 ABHD2 NTRK2 CNKSR3

1.83e-05194187789812fb164065041357bb37a3c2d87028ec3de4e
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

STAG1 ADGRB3 CHD9 PTGIS PRELP LRP1 KAZN

1.83e-051941877234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 CHD4 HUWE1 DST AKAP9 DYNC1H1 GOLGA4

1.89e-0519518773e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FILIP1 CHD4 HUWE1 DST AKAP9 DYNC1H1 GOLGA4

1.89e-0519518777796ea9247f4c63762f0de8490fed08b9717fa23
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAG1 ENPP2 SMC1A CHD9 AKAP9 PRELP LRP1

1.89e-0519518775c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellCOPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class

ANK3 ABCA13 CYP4B1 SYNE1 ARHGEF12 ARFGEF3 CNKSR3

1.96e-051961877af4cdc61830685a888a1209826c23bcf54a43084
ToppCellCOPD-Multiplet|COPD / Disease state, Lineage and Cell class

ANK3 ABCA13 CYP4B1 SYNE1 ARHGEF12 ARFGEF3 CNKSR3

1.96e-0519618776d02d494196e3f857d53eea46d9419690d43beca
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK2 ANK3 NRCAM VEPH1 EVC CCDC198 KAZN

1.96e-051961877eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SYNE1 RNF213 STK10 TRANK1 NLRC5 ATM LGR6

2.02e-051971877836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ANK3 ENPP2 ARFGEF3 DST TMTC4 PACS2 CARNS1

2.02e-05197187782b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell(5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

FILIP1 CYP3A5 CYP4B1 MEI1 ITPR1 DST PRELP

2.02e-051971877a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FILIP1 SYNE1 ADAM12 EDNRB MDN1 MAP4K5 KAZN

2.09e-051981877a860246bcea847249a78fd2e86ed8e04371060db
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

CNTRL MAN1A2 AKAP9 MAP4K5 ROCK1 NIPBL GOLGA4

2.09e-05198187776d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellCOVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SYNE1 RNF213 JAK1 STK10 TRANK1 ATM LGR6

2.16e-051991877df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

ARHGEF12 MAN1A2 AKAP9 CRYBG1 ROCK1 NIPBL GOLGA4

2.16e-05199187718a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

MAN1A2 AKAP9 MAP4K5 ROCK1 NIPBL GOLGA4 ZNF292

2.16e-05199187753ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCellCOVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SYNE1 RNF213 JAK1 STK10 TRANK1 ATM LGR6

2.16e-051991877ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

CNTNAP3B ANK2 ANK3 ARHGEF12 ARFGEF3 DST AKAP9

2.16e-0519918771b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

MAN1A2 AKAP9 MAP4K5 ROCK1 EIF3M GOLGA4 ZNF292

2.16e-051991877d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

CNTNAP3B ANK2 ANK3 ARHGEF12 ARFGEF3 DST AKAP9

2.16e-0519918774bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

FILIP1 CYP3A5 ENPP2 DST AKAP9 PRELP FTL

2.16e-051991877212e89d097753790061310373a1fafba773488b6
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PSAT1 BEX1 VEPH1 ADGRB3 EDNRB DST WNT16

2.16e-051991877a816b0eed80530113b7e720bbd2311a544ed8ed1
ToppCell343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

FILIP1 CYP3A5 ENPP2 DST AKAP9 PRELP FTL

2.16e-05199187714b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

MAN1A2 AKAP9 ROCK1 NIPBL EIF3M GOLGA4 ZNF292

2.16e-051991877a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCellLPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

KAT6A ARHGEF12 RNF213 EDNRB DST CASKIN2 DYNC1H1

2.23e-05200187772ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ENPP2 BEX1 ARHGEF12 RNF213 DST FGD6 NIPBL

2.23e-052001877dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic

CNTNAP3B ANK1 CNTNAP3 HPSE2 ADAM12 WNT16 PCDH8

2.23e-0520018772441a36d363b799a4692aa697f969cda056c2d60
ToppCellmLN-Mast_cell-Mast|mLN / Region, Cell class and subclass

ENPP2 BEX1 ARHGEF12 ADAM12 EDNRB VWA5A DHRS9

2.23e-05200187781ea6e7a3940277751faf9097b30198159998c7b
ToppCellLPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

KAT6A ARHGEF12 RNF213 EDNRB DST CASKIN2 DYNC1H1

2.23e-0520018775c092b2ecc081b5d04476c56333c338cd89ab984
ToppCellmLN-Mast_cell|mLN / Region, Cell class and subclass

ENPP2 BEX1 ARHGEF12 ADAM12 EDNRB VWA5A DHRS9

2.23e-0520018779a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad
ToppCellmLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype

ENPP2 BEX1 ARHGEF12 ADAM12 EDNRB VWA5A DHRS9

2.23e-052001877a6c258cae678be581b1d85cf3446c65c34b13499
ToppCellCOVID-19|World / Disease, condition lineage and cell class

RNF213 CHD4 JAK1 ROCK1 NIPBL DYNC1H1 GOLGA4

2.23e-0520018777dec470c379cd89f05a0f37c8628b21f136e52f0
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SYNE1 AKAP9 ROCK1 ATM DYNC1H1 GOLGA4 ZNF292

3.73e-07491037GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SYNE1 ARHGEF12 RNF213 DST DYNC1H1

1.10e-04501035GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
DrugThimerosal

PHF20 ANK2 STAG1 PDK1 SMC1A KAT6A CDC20B ARHGEF12 CHD9 CHD4 SHOC2 C2CD2 EDNRB TDRD7 ARFGEF3 USP10 DST AKAP9 EML5 ARHGEF10 MAP4K5 MICA ATM LGR6 MAPK8 FGD6 NIPBL VCP

5.17e-07119918628ctd:D013849
DrugMeclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A

ANK3 ADAM12 PACS1 BPNT2 AKAP9 NDUFAF7 ACIN1 LONRF3 TRAPPC14 LYN ZNF292

5.46e-07192186117280_DN
DrugTHIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A

PDK1 ARHGEF12 PPFIA3 ITPR1 BPNT2 XPNPEP3 CRYBG1 KAZN TRAPPC14 LYN EIF3M

7.41e-07198186117266_DN
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

ANK2 TBC1D30 PDK1 NUMA1 MDN1 TSR1 DHRS9 KAZN EIF3M PUS7

3.53e-06188186106186_DN
DrugEthoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

ANK3 COPA BEX1 NTRK2 NUMA1 ARHGEF12 SRSF11 CHD4 PACS1 CD101

4.46e-06193186104321_DN
DrugGramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A

CEP104 PHF20 NTRK2 SMC1A CNTRL MAN1A2 XPNPEP3 ATM MAPK8 EIF3M

4.46e-06193186104118_DN
DrugOzagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; HL60; HT_HG-U133A

CEP104 PHF20 NRCAM COPA NR1D1 CDK10 PRELP QSER1 TRAPPC14 MAPK8

5.11e-06196186102942_DN
DrugThiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A

NTRK2 KAT6A NR1D1 ITPR1 PACS1 MAN1A2 CD101 WNT16 MIOS MAPK8

5.35e-06197186102752_UP
DrugHarmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A

STAG1 SYNE1 SMC1A ARHGEF12 ADAM12 CDK10 ITPR2 DIMT1 MAP4K5 MAPK8

5.59e-06198186104584_DN
DrugFenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A

NRCAM CYP3A5 HUWE1 ITPR2 TRANK1 MAN1A2 CCDC198 LRRC31 CARD9 WNT16

5.85e-06199186103805_UP
DrugClorgyline

CHD9 RICTOR SHOC2 DST AKAP9 SLITRK6 NIPBL GOLGA4 ZNF292

1.03e-051681869ctd:D003010
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

KNTC1 PHF20 TBC1D30 STAG1 PPFIA1 CHD9 MDN1 PIK3C3 NIPBL

2.05e-0518318697498_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

TBC1D30 CHD9 C2CD2 ZNHIT6 TBK1 MIOS NIPBL ZNF292 SOS2

2.14e-0518418692321_DN
Drugthioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A

CEP104 TBC1D30 KAT6A C2CD2 MDN1 CARD9 XPNPEP3 TRAPPC9 PUS7

2.64e-0518918691171_DN
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

BEX1 SMC1A KAT6A NUMA1 CHD4 HAUS2 XPNPEP3 ATM SOS2

2.87e-0519118694283_DN
DrugPimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A

ABHD2 LIG3 CASKIN2 XPNPEP3 TRAPPC14 LYN FGD6 EIF3M ZNF292

3.38e-0519518697426_DN
DrugZalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A

CEP104 NUMA1 ITPR1 ITPR2 ARHGEF10 VWA5A NDUFAF7 ATM SOS2

3.38e-0519518694799_UP
DrugErgocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A

ANK3 NRCAM CNTRL ADGRB3 VWA5A LRP1 MIOS TRAPPC9 SOS2

3.52e-0519618693817_UP
DrugStrophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A

CEP104 PPFIA3 NR1D1 PACS1 LIG3 PACS2 TRAPPC9 RBM34 SOS2

3.52e-0519618697182_UP
DrugPNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A

TBC1D30 COPA CYP3A5 KAT6A ITPR2 PKNOX2 PRELP DHRS9 SOS2

3.52e-0519618694291_UP
Drugamitriptyline hydrochloride; Down 200; 1uM; MCF7; HG-U133A

STAG1 CDK10 LIG3 BPNT2 VWA5A XPNPEP3 HSD17B3 TRAPPC14 NIPBL

3.52e-051961869167_DN
DrugHydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A

ARHGEF12 PPFIA3 ANKRD27 ITPR1 LIG3 ACIN1 ATM LONRF3 NIPBL

3.52e-0519618692119_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A

STAG1 SRSF11 ITPR1 LIG3 THADA DIMT1 TSR1 CARD9 PUS7

3.52e-0519618692035_DN
Drug2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A

PHF20 ANK3 NRCAM SMC1A KAT6A ADAM12 VWA5A WNT16 SOS2

3.81e-0519818694464_DN
DrugProparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A

STAG1 EVC ADAM12 ITPR1 NDUFAF7 TBK1 PACS2 NIPBL MED12

3.81e-0519818696332_DN
Drug3-doxylandrostanol

ANK1 ANK2 ANK3

4.35e-0591863CID000189075
Drug1pzj

SYNE1 LARS2 JAK1 DROSHA DHRS9 MAPK8 DYNC1H1 GOLGA4

7.15e-051671868CID000447976
Drug26-nor-25-doxylcholestanol

ANK1 ANK2 ANK3

8.44e-05111863CID000125890
DrugAC1NSPXR

ANK1 ANK2 ANK3

8.44e-05111863CID005313815
Drugdelta 8-THC

CYP3A5 DST TBK1

8.44e-05111863CID000002977
Drugdimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A

PDK1 ADAM12 ITPR1 PRELP LRP1 TRAPPC14 MAPK8 ZNF292

8.79e-051721868584_UP
Drugxestospongin C

ENPP2 ITPR1 ITPR2

1.12e-04121863ctd:C511704
DrugPD-V

STAG1 SYNE1 ASL

1.12e-04121863CID000444615
Druggeldanamycin; Up 200; 1uM; PC3; HT_HG-U133A

SYNE1 HUWE1 PTGIS VWA5A DHRS9 MAPK8 TRAPPC9 RBM34

1.16e-0417918684452_UP
DrugDihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; HL60; HT_HG-U133A

ANK2 TBC1D30 LIG3 MDN1 DIMT1 TSR1 DHRS9 PUS7

1.25e-0418118682136_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

TBC1D30 CHD9 PPWD1 ZNHIT6 AKAP9 TBK1 NIPBL SOS2

1.30e-0418218683887_DN
Drugmancozeb

SYNE1 TRIM11 VCP

1.44e-04131863CID003034368
DrugProgesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A

TBC1D30 KAT6A NUMA1 TRANK1 ARHGEF10 KAZN TRAPPC14 ZNF292

1.51e-0418618682426_DN
DrugClioquinol

NUMA1 AKAP9 DROSHA ATM MAPK8

1.53e-04621865ctd:D007464
DrugSulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A

ANK3 COPA KAT6A NUMA1 SRSF11 CHD4 VWA5A SOS2

1.75e-0419018684322_DN
DrugBenfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; HL60; HT_HG-U133A

ANK2 COPA SMC1A DIMT1 DHRS9 LONRF3 NIPBL SOS2

1.88e-0419218681266_DN
DrugClorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A

TBC1D30 COPA ARHGEF12 ADAM12 VWA5A XPNPEP3 FGD6 SOS2

1.88e-0419218686659_DN
DrugEquilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A

ANK1 NTRK2 CNTRL NR1D1 ADAM12 ITPR1 MAN1A2 CARD9

1.88e-0419218685620_UP
DrugAntimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A

TBC1D30 ARHGEF12 EVC SRSF11 ADAM12 LIG3 NIPBL TRAPPC9

1.95e-0419318682098_DN
DrugCalycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A

ANK1 SYNE1 KAT6A ARHGEF12 PPFIA3 ITPR1 PKNOX2 LONRF3

1.95e-0419318682764_UP
DrugEthynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A

BEX1 NTRK2 HUWE1 ITPR2 PKNOX2 WNT16 XPNPEP3 DHRS9

1.95e-0419318686678_UP
DrugPodophyllotoxin [518-28-5]; Down 200; 9.6uM; HL60; HT_HG-U133A

TBC1D30 LIG3 DIMT1 TSR1 CARD9 KAZN EIF3M PUS7

1.95e-0419318682540_DN
Drugiminophosphamide

CYP3A5 SYNE1

1.98e-0431862CID000134773
DrugPHA-00846566E [724718-26-7]; Up 200; 10uM; PC3; HT_HG-U133A

SMC1A CNTRL ARHGEF12 ITPR2 ROCK1 ATM NIPBL EIF3M

2.02e-0419418687086_UP
DrugIndomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A

CEP104 ANK3 COPA SYNE1 SMC1A CNTRL ARHGEF12 SOS2

2.02e-0419418685049_DN
DrugSpiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A

NTRK2 KAT6A NUMA1 SRSF11 CHD4 DIMT1 VWA5A CD101

2.02e-0419418684319_DN
DrugMethoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A

PHF20 CYP3A5 SYNE1 NUMA1 WNT16 MIOS ATM LONRF3

2.02e-0419418682893_UP
DrugFelodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A

TBC1D30 ENPP2 NUMA1 NR1D1 VWA5A XPNPEP3 PACS2 ATM

2.02e-0419418682433_DN
DrugMetronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A

PHF20 SMC1A NUMA1 MAN1A2 ARHGEF10 XPNPEP3 ATM MAPK8

2.02e-0419418684141_DN
DrugPhentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A

NR1D1 ADAM12 LIG3 VWA5A DHRS9 TTC12 RBM34 SOS2

2.02e-0419418683779_DN
DrugReserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A

ENPP2 ARHGEF12 CDK10 VWA5A WNT16 LRP1 MAPK8 SOS2

2.09e-0419518684203_UP
Drug(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A

PHF20 COPA SMC1A PPFIA3 ITPR1 VWA5A QSER1 RBM34

2.09e-0419518684980_DN
DrugEtomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A

SMC1A CDK10 PACS1 THADA CASKIN2 TRAPPC14 LYN MED12

2.09e-0419518683519_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A

CEP104 ABHD2 SMC1A SRSF11 ADAM12 PPWD1 CDK10 ITPR1

2.09e-0419518683710_DN
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A

NRCAM CNTRL NUMA1 CDK10 AKAP9 TSR1 MAP4K5 LYN

2.09e-0419518681665_DN
DrugSB 202190; Down 200; 1uM; MCF7; HT_HG-U133A

COPA ABHD2 NUMA1 PTGIS ITPR1 MAP4K5 NDUFAF7 SOS2

2.09e-0419518687054_DN
DrugHydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A

ANK3 NTRK2 CNTRL ITPR1 CASKIN2 VWA5A MAP4K5 LYN

2.09e-0419518682311_DN
DrugEpiandrosterone [481-29-8]; Down 200; 13.8uM; HL60; HT_HG-U133A

PHF20 ENPP2 NR1D1 BPNT2 WNT16 KAZN TRAPPC14 SOS2

2.09e-0419518682444_DN
DrugAdenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A

PDK1 PSMD11 ITPR2 CCDC198 MAP4K5 ATM MAPK8 SOS2

2.09e-0419518683237_DN
DrugPiromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A

PHF20 ABHD2 NUMA1 NR1D1 NDUFAF7 ATM TRAPPC14 SOS2

2.09e-0419518684398_DN
DrugPargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A

PPFIA3 ADAM12 ARHGEF10 XPNPEP3 HSD17B3 TRAPPC14 MAML3 MED12

2.16e-0419618681418_UP
DrugChlormezanone [80-77-3]; Down 200; 14.6uM; HL60; HG-U133A

ENPP2 NR1D1 ITPR1 ATM LYN NIPBL TRAPPC9 VCP

2.16e-0419618681620_DN
Drugalpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA

COPA PDK1 ABHD2 ITPR1 DIMT1 ARHGEF10 QSER1 TRAPPC9

2.16e-041961868990_UP
DrugChlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A

TBC1D30 NUMA1 CHD9 SRSF11 LARS2 ADAM12 DIMT1 EIF3M

2.16e-0419618686692_DN
DrugOxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A

SYNE1 BEX1 KAT6A THADA CASKIN2 TTC12 TRAPPC14 SOS2

2.16e-0419618686309_DN
DrugPancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A

NUMA1 PPFIA3 PACS1 THADA MAN1A2 AKAP9 XPNPEP3 TRAPPC14

2.16e-0419618687329_DN
DrugMetrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A

ANK1 ANK2 NRCAM ENPP2 ABHD2 HPSE2 HUWE1 AKAP9

2.16e-0419618684075_UP
DrugSulfaguanidine [57-67-0]; Down 200; 18.6uM; HL60; HG-U133A

CEP104 RANBP2 PPFIA1 ACIN1 ATM LONRF3 TRAPPC14 VCP

2.16e-0419618681995_DN
DrugMethoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A

CEP104 PSMD11 ITPR1 ITPR2 LIG3 KAZN QSER1 TRAPPC9

2.24e-0419718682848_DN
DrugAH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A

PHF20 COPA ABHD2 CNTRL PPFIA3 KAZN TRAPPC14 SOS2

2.24e-0419718686890_UP
DrugMeticrane [1084-65-7]; Down 200; 14.6uM; PC3; HT_HG-U133A

ANK3 PPFIA3 ADAM12 CASKIN2 MAP4K5 LYN NIPBL SOS2

2.24e-0419718687282_DN
Drugfelodipine; Up 200; 10uM; MCF7; HG-U133A

CYP3A5 ABHD2 PSMD11 EDNRB ITPR2 LIG3 KAZN TRAPPC14

2.24e-041971868337_UP
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

SMC1A PSMD11 C2CD2 MDN1 TSR1 DHRS9 PACS2 PUS7

2.24e-0419718681180_DN
DrugMafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A

RANBP2 STAG1 PDK1 ARHGEF12 SRSF11 NIPBL MAML3 EIF3M

2.24e-0419718681441_UP
DrugStreptozotocin [18883-66-4]; Up 200; 15uM; MCF7; HT_HG-U133A

TBC1D30 AKAP9 TSR1 NDUFAF7 ATM FGD6 TRAPPC9 SOS2

2.24e-0419718687193_UP
DrugTicarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A

TBC1D30 CYP3A5 PDK1 ENPP2 NUMA1 EVC MAP4K5 SOS2

2.32e-0419818685829_UP
DrugCanrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A

ANK3 PACS1 LIG3 AKAP9 CASKIN2 DHRS9 LRP1 MAPK8

2.32e-0419818682065_UP
DrugCefotetan [69712-56-7]; Down 200; 7uM; MCF7; HT_HG-U133A

CEP104 PHF20 ABHD2 SMC1A CNTRL ARHGEF12 CDK10 MAN1A2

2.32e-0419818684116_DN
DrugDantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A

TBC1D30 NTRK2 KAT6A NUMA1 NR1D1 CDK10 MAPK8 SOS2

2.32e-0419818684343_UP
DrugRitodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A

PHF20 CYP3A5 CYP4B1 ENPP2 SYNE1 EDNRB ITPR1 PKNOX2

2.32e-0419818685680_UP
Drug0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A

KAT6A NUMA1 PPFIA3 ADAM12 PACS1 LIG3 CFAP74 SOS2

2.32e-0419818686426_UP
DrugMoroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A

ABHD2 ARHGEF12 CHD9 SRSF11 AKAP9 XPNPEP3 ATM TRAPPC14

2.32e-0419818685304_UP
DrugTodralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A

NRCAM CYP3A5 SYNE1 MAN1A2 DIMT1 ARHGEF10 LRP1 MAPK8

2.32e-0419818685087_UP
DrugSalsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A

ARHGEF12 PPFIA3 ITPR1 PKNOX2 PACS1 VWA5A KAZN TRAPPC9

2.32e-0419818682791_UP
DrugCaffeic acid [3331-39-5]; Up 200; 22.2uM; HL60; HT_HG-U133A

ANK3 NRCAM ITPR2 PKNOX2 LIG3 TRANK1 DIMT1 TRAPPC9

2.32e-0419818683053_UP
DrugMetampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

PHF20 COPA SMC1A PPFIA3 CDK10 STK10 TSR1 CASKIN2

2.40e-0419918685540_UP
DrugBromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A

COPA ABHD2 PSMD11 CDK10 ITPR2 MAP4K5 TRAPPC14 NIPBL

2.40e-0419918682872_DN
DrugThiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A

ABHD2 BEX1 SMC1A SRSF11 RSU1 PACS1 MED4 LYN

2.40e-0419918685095_DN
DrugFurosemide [54-31-9]; Down 200; 12uM; HL60; HG-U133A

GPAA1 PPFIA1 NR1D1 LIG3 DIMT1 CARD9 ACIN1 TRAPPC9

2.40e-0419918681580_DN
DrugDoxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; PC3; HT_HG-U133A

NUMA1 PACS1 ATM TRAPPC14 NIPBL TRAPPC9 VCP ZNF292

2.40e-0419918685838_DN
DrugHomosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A

BEX1 NTRK2 PTGIS LRP1 MIOS MAPK8 RBM34 SOS2

2.40e-0419918684533_UP
DrugProcainamide hydrochloride [614-39-1]; Up 200; 14.8uM; HL60; HT_HG-U133A

PPFIA1 NUMA1 ARHGEF12 SRSF11 NR1D1 CDK10 KAZN SOS2

2.48e-0420018681263_UP
DrugRacecadotril [81110-73-8]; Up 200; 10.4uM; PC3; HT_HG-U133A

PHF20 CYP3A5 NTRK2 PKNOX2 PACS1 LIG3 VWA5A SOS2

2.48e-0420018685755_UP
DrugChlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A

PDK1 KAT6A ARHGEF12 ITPR2 CASKIN2 TRAPPC9 RBM34 ZNF292

2.48e-0420018685403_DN
DrugEpiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A

CNTRL NUMA1 PACS1 LONRF3 MAPK8 LYN MED12 SOS2

2.48e-0420018685687_DN
DiseaseSchizophrenia

ANKK1 PSAT1 RAPGEF6 ANK3 HTR7 CYP3A5 ABCA13 NTRK2 CHD4 LARS2 ADAM12 PKNOX2 EML5 PIK3C3 LRP1 ATM MAPK8 PCDH8 MED12

3.25e-0688318519C0036341
DiseaseMalignant neoplasm of breast

ANK1 ANK2 NRCAM SYNE1 BCAR1 ADAM12 HELQ EDNRB AKAP9 TMTC4 ASL NLRC5 ATM LGR6 LONRF3 FASTKD3 PCDH8 NIPBL EIF3M MED12 NLRP8

4.28e-06107418521C0006142
DiseaseHypoxic Brain Damage

ITPR1 ITPR2

3.91e-0521852C1140716
DiseaseAnoxic Encephalopathy

ITPR1 ITPR2

3.91e-0521852C0003132
DiseaseBrain Hypoxia

ITPR1 ITPR2

3.91e-0521852C1527348
DiseaseAnoxia of brain

ITPR1 ITPR2

3.91e-0521852C0995195
DiseaseColorectal Carcinoma

SALL3 ANK2 NRCAM ABCA13 SYNE1 LIG3 ZNHIT6 AKAP9 WNT16 LRP1 ACIN1 C2CD6 LGR6 NLRP8 ZNF292

3.98e-0570218515C0009402
Diseaseautism spectrum disorder (implicated_via_orthology)

CNTNAP3B NRCAM CNTNAP3 CHD9 ARHGEF10 CHD6 GPRASP2

5.11e-051521857DOID:0060041 (implicated_via_orthology)
DiseaseBipolar Disorder

ANKK1 ANK3 ABCA13 SYNE1 NTRK2 LARS2 NR1D1 ITPR1 PACS1 TRANK1 ARHGEF10 PIK3C3

5.20e-0547718512C0005586
Diseasebreast ductal carcinoma (is_implicated_in)

RICTOR BCAR1

1.17e-0431852DOID:3007 (is_implicated_in)
DiseaseProstatic Neoplasms

CYP3A5 KAT6A BCAR1 ITPR1 JAK1 CHD6 ATM HSD17B3 PCDH8 MED12 GOLGA4 VCP ZNF292

1.48e-0461618513C0033578
DiseaseMalignant neoplasm of prostate

CYP3A5 KAT6A BCAR1 ITPR1 JAK1 CHD6 ATM HSD17B3 PCDH8 MED12 GOLGA4 VCP ZNF292

1.48e-0461618513C0376358
Diseasebody weight

KNTC1 NRCAM NTRK2 ADGRB3 ARHGEF12 ATP13A5 ZSWIM6 HUWE1 PPFIA3 CWC22 RSU1 CDK10 ITPR1 MAP4K5 ASL MICA KAZN NIPBL MAML3

3.84e-04126118519EFO_0004338
Diseasecolorectal adenoma (is_implicated_in)

PTGIS MAPK8

3.86e-0451852DOID:0050860 (is_implicated_in)
DiseaseCongenital muscular hypertrophy-cerebral syndrome

SMC1A NIPBL

3.86e-0451852C1802395
DiseaseCornelia de Lange Syndrome 3

SMC1A NIPBL

3.86e-0451852C1853099
DiseaseCornelia de Lange Syndrome 1

SMC1A NIPBL

3.86e-0451852C4551851
DiseaseDepressive disorder

ANKK1 HTR7 NTRK2 NR1D1 ARHGEF10 FTL MAPK8 MED12

5.04e-042891858C0011581
DiseaseDe Lange syndrome

SMC1A NIPBL

5.77e-0461852cv:C0270972
DiseaseCornelia de Lange syndrome (implicated_via_orthology)

SMC1A NIPBL

5.77e-0461852DOID:11725 (implicated_via_orthology)
DiseaseAlcohol Related Birth Defect

ANK3 NTRK2

5.77e-0461852C3146244
Diseaseprimary ciliary dyskinesia (is_implicated_in)

STK36 CFAP74

5.77e-0461852DOID:9562 (is_implicated_in)
Diseaseepilepsy (implicated_via_orthology)

ANK2 NRCAM KCNU1 LRP1 KCNT1 DYNC1H1

5.89e-041631856DOID:1826 (implicated_via_orthology)
DiseaseChild Development Disorders, Specific

NTRK2 CHD4 KCNT1

7.86e-04291853C0085997
DiseaseChild Development Deviations

NTRK2 CHD4 KCNT1

7.86e-04291853C0085996
DiseaseCHARGE syndrome (implicated_via_orthology)

CHD9 CHD6

8.04e-0471852DOID:0050834 (implicated_via_orthology)
Diseasedisease of cellular proliferation (implicated_via_orthology)

JAK1 ATM

8.04e-0471852DOID:14566 (implicated_via_orthology)
DiseaseDevelopmental Disabilities

NTRK2 CHD4 KCNT1

8.69e-04301853C0008073
DiseaseManic Disorder

ANK3 NTRK2 PACS1 TRANK1

1.05e-03711854C0024713
DiseaseFrontotemporal Dementia With Motor Neuron Disease

TBK1 VCP

1.07e-0381852C3888102
Diseaseautosomal recessive intellectual developmental disorder (implicated_via_orthology)

CNTNAP3B CNTNAP3

1.07e-0381852DOID:0060308 (implicated_via_orthology)
DiseaseCornelia De Lange Syndrome

SMC1A NIPBL

1.07e-0381852C0270972
Diseasetestosterone measurement

SLC22A25 ANK2 ANK3 STAG1 TFAP2E CYP4B1 CWC22 RSU1 C2CD2 PKNOX2 THADA ANAPC1 MAP4K5 CNKSR3 C18orf63 KAZN MED12 SOS2

1.15e-03127518518EFO_0004908
Diseaseintellectual disability (implicated_via_orthology)

ANK2 GPRASP2 TRAPPC9 PUS7

1.28e-03751854DOID:1059 (implicated_via_orthology)
Diseaseunderweight body mass index status

ANK2 ADGRB3

1.37e-0391852EFO_0005936
Diseaseserine measurement

PACS1 MAP4K5 DYNC1H1

1.37e-03351853EFO_0009774
DiseaseManic

ANK3 NTRK2 PACS1 TRANK1

1.49e-03781854C0338831
DiseaseDepression, Bipolar

ANK3 NTRK2 PACS1 TRANK1

1.56e-03791854C0005587
DiseaseAlcoholic Intoxication, Chronic

ANKK1 HTR7 NTRK2 PKNOX2 ANAPC1 TTC12 EPHA8

1.57e-032681857C0001973
DiseaseEssential hypertension

CYP3A5 PTGIS

1.70e-03101852cv:C0085580
DiseaseEssential hypertension, genetic

CYP3A5 PTGIS

1.70e-03101852cv:CN305331
DiseaseHYPERTENSION, ESSENTIAL

CYP3A5 PTGIS

1.70e-03101852145500
Diseaseglycerophosphorylcholine measurement

JAK1 EPHA8

2.07e-03111852EFO_0020018
DiseaseIntellectual Disability

STAG1 SYNE1 CDK10 PACS1 ACIN1 PACS2 DYNC1H1 PUS7 ZNF292

2.14e-034471859C3714756
Diseaseage-related macular degeneration, disease progression measurement

CYP4B1 PKNOX2 TRAPPC9

2.17e-03411853EFO_0001365, EFO_0008336
Diseaseautosomal dominant cerebellar ataxia (implicated_via_orthology)

ITPR1 ITPR2

2.48e-03121852DOID:1441 (implicated_via_orthology)
Diseaseresponse to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent

KAZN FGD6

2.48e-03121852GO_0097327, GO_0097328, MONDO_0009354
DiseaseEssential Hypertension

CYP3A5 PTGIS

2.48e-03121852C0085580
Disease1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement

MAP4K5 ROCK1

2.48e-03121852EFO_0800453
Diseasebrain disease (is_implicated_in)

RANBP2 TBK1

2.48e-03121852DOID:936 (is_implicated_in)
DiseaseNeurodevelopmental Disorders

ANK2 SMC1A ITPR1 ZNF292

2.83e-03931854C1535926
Diseasealcohol and nicotine codependence

RGPD2 PKNOX2

2.91e-03131852EFO_0004776
Diseaselevel of Phosphatidylcholine (16:1_18:1) in blood serum

MAP4K5 ROCK1

2.91e-03131852OBA_2045082
Diseasebipolar disorder

ANK3 SYNE1 ZSWIM6 HUWE1 PTGIS PACS1 TRANK1 KCNU1 XPNPEP3 PUS7

3.64e-0357718510MONDO_0004985
DiseaseAdenoid Cystic Carcinoma

SMC1A KAT6A ATM MAML3

3.67e-031001854C0010606
Diseaseattention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia

ANK3 SYNE1 CWC22 CDK10

3.81e-031011854EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
DiseaseRomano-Ward Syndrome

ANK2 AKAP9

4.43e-03161852C0035828
DiseaseIntrahepatic cholestasis of pregnancy

MAP4K5 DHRS9

4.43e-03161852EFO_0009048
Diseasemigraine without aura, susceptibility to, 4

HPSE2 LRP1

4.43e-03161852MONDO_0011847
Diseasesmoking cessation

ANK3 STAG1 ENPP2 VEPH1 MEI1 TTC12 MAML3

4.57e-033251857EFO_0004319
Diseasemajor depressive disorder (is_implicated_in)

NTRK2 MED12

5.00e-03171852DOID:1470 (is_implicated_in)
Diseaselevel of Phosphatidylcholine (14:0_18:2) in blood serum

MAP4K5 ROCK1

5.00e-03171852OBA_2045063
DiseaseIschemic stroke, fibrinogen measurement

RAPGEF6 STAG1 CHD9

5.01e-03551853EFO_0004623, HP_0002140
DiseaseMental Depression

ANKK1 HTR7 NTRK2 ARHGEF10 MAPK8 MED12

5.48e-032541856C0011570
Diseaseessential hypertension (is_implicated_in)

CYP3A5 PTGIS

5.60e-03181852DOID:10825 (is_implicated_in)
Diseasemigraine disorder, systolic blood pressure

RNF213 HPSE2

5.60e-03181852EFO_0006335, MONDO_0005277
Diseasefibrinogen measurement, factor VII measurement

RAPGEF6 STAG1 MAP4K5

5.81e-03581853EFO_0004619, EFO_0004623
Diseaseinsulin resistance

ANK2 KCNU1 MAP4K5

6.09e-03591853EFO_0002614
DiseaseNoonan-Like Syndrome With Loose Anagen Hair

SHOC2 SOS2

6.23e-03191852C3501846
DiseaseNoonan syndrome-like disorder with loose anagen hair

SHOC2 SOS2

6.23e-03191852C1843181
DiseaseCardio-facio-cutaneous syndrome

SHOC2 SOS2

6.23e-03191852C1275081
Diseasesensorineural hearing loss (implicated_via_orthology)

EDNRB SLITRK6

6.23e-03191852DOID:10003 (implicated_via_orthology)
DiseaseCostello syndrome (disorder)

SHOC2 SOS2

6.23e-03191852C0587248
Diseasehydrocephalus (implicated_via_orthology)

STK36 POMK

6.23e-03191852DOID:10908 (implicated_via_orthology)
Diseaseleukemia (implicated_via_orthology)

PKNOX2 ATM

6.23e-03191852DOID:1240 (implicated_via_orthology)
Diseasetriglyceride measurement, body mass index

STK36 MAP4K5

6.23e-03191852EFO_0004340, EFO_0004530

Protein segments in the cluster

PeptideGeneStartEntry
RLKGALMLENLQKHS

ACIN1

101

Q9UKV3
ALHAQMNGRKITLKR

AKAP9

3096

Q99996
ILLLQDMLKNTSKGH

ARHGEF10

571

O15013
RVIALAHKTLKMGNL

ATP13A5

656

Q4VNC0
KFKAMQSNGILLHRE

CNTNAP3

211

Q9BZ76
LRRKLKLGTGEMNIH

CNTRL

816

Q7Z7A1
LKSLHGTVMKINQER

CNTRL

1001

Q7Z7A1
QLMEKLREKQLSHSL

BEX1

91

Q9HBH7
ALHAKLSRQLQKMED

BCAR1

536

P56945
LLRKNHSIMQLCNSK

ADGRB3

101

O60242
LNDKQKHRLDFLQLM

CYP3A5

261

P20815
ADNMKKIILSHRQAL

ABHD2

261

P08910
KNHVRVMELLLKTGA

ANK1

381

P16157
LKPGNILLDSNMHVK

ANKK1

146

Q8NFD2
AAMRLAKQKSLTQLH

CARNS1

496

A5YM72
RHLLSEMNKGIKSIN

ABCA13

2076

Q86UQ4
LMLLQDSNKKSHIAL

ABCA13

4156

Q86UQ4
KMKLLPRKSHDNAQL

ADAM12

291

O43184
LRKKSGMQIALNDHL

EDNRB

301

P24530
SKLTNNFEKLRLHQM

DEUP1

101

Q05D60
LQLEIDQLKHSLMKA

CARD9

206

Q9H257
LHIGLNEQMKAVRKR

ARHGEF12

841

Q9NZN5
GELHSRKSMLLAAKQ

TFAP2E

336

Q6VUC0
QLGAHLEQLKMTIKS

CFAP206

296

Q8IYR0
HMLLNLSRGKQDFLK

RANBP2

356

P49792
VHLALKLNNSELMGR

RBM34

341

P42696
GMLNDNRKRLLLNLH

QSER1

1586

Q2KHR3
DLMSHLKKQILRTDN

JAK1

521

P23458
ARHNKLLQQMLKPGS

ITPR2

2116

Q14571
MPLLQTLDNLKEGKH

KCTD19

96

Q17RG1
IRMLLNQHSLLFGGK

PDK1

191

Q15118
LRMTLAHIKDQKEGL

MICA

96

Q29983
GNLKVLQLCRFLHMK

ANAPC1

1531

Q9H1A4
HVASKRGNTNMVKLL

ANK2

271

Q01484
LQQLLRDSHLKMLAK

ANKRD27

186

Q96NW4
KHNKIPRSELLNELM

PTCD3

601

Q96EY7
AKHILMQKQRALSDL

MDN1

4116

Q9NU22
MQKQRALSDLFKHLA

MDN1

4121

Q9NU22
IPHLAANLKKMNQAL

HAUS2

156

Q9NVX0
NSLMKRDLEKHLNVS

KAZN

556

Q674X7
AHLSEDQKRLLLMKQ

MAML3

661

Q96JK9
GKALEGMFRKLNHLL

GPAA1

336

O43292
MNQKLLKLENLLRFH

MTIF2

1

P46199
LPLDMAALVHAKKAQ

NRAP

1116

Q86VF7
VARNKLGMAKNEVHL

NRCAM

526

Q92823
RLSNAKKQALHAVMG

GPR162

126

Q16538
LARHNKELQSMLKPG

ITPR1

2171

Q14643
MLRKNQHLRHLDLSK

NLRP8

976

Q86W28
MHLKLKGNLALSQAF

LGR6

446

Q9HBX8
LELKHNSTLKQLMRE

GOLGA4

1986

Q13439
DILKSRLKEGHMNPQ

DST

3146

Q03001
MALEKKLNQALLDLH

FTL

101

P02792
LIKKMGDHLTNLHRL

FTL

141

P02792
NKHVGSNMKLLRVDI

LRP1

2446

Q07954
ARMLDHLNKKELRGQ

PPFIA3

981

O75145
KAGLLTKAEMDQILH

ASL

51

P04424
LGLLHEQNMAKMRLL

EIF3M

266

Q7L2H7
HNGLQMILEDKRILK

EXD1

141

Q8NHP7
QELSELVKNRMKHLG

KCNT1

1121

Q5JUK3
TNKLRNVAKMFAHLL

CWC22

541

Q9HCG8
TGHRLLNMLRKTLKE

C2CD6

71

Q53TS8
LMKCVNHKNIIGLLN

MAPK8

76

P45983
ISGDALKKDLINHMQ

PCDH8

931

O95206
QQMHLVSKLKILRLG

LRRC31

136

Q6UY01
MHQLFRLVLGQKDLS

VEPH1

1

Q14D04
LLMLKQHLKNLCGFS

NIPBL

2546

Q6KC79
LGATHKELMILKEQN

PPFIA1

196

Q13136
ARMLDHLTKKDLRGQ

PPFIA1

991

Q13136
KLHRQALALQMSKQE

KNTC1

1051

P50748
KQLMHEALKLRLNLV

MED12

1526

Q93074
HFLNSMKNKILTQRL

KCNU1

516

A8MYU2
FQELMKLALNQGKIH

MED4

76

Q9NPJ6
PHFLKREGNKLQIML

PACS2

101

Q86VP3
CIIRLIKHDLKMNSG

LIG3

411

P49916
LQREKAAQMHLVLLK

HPSE2

176

Q8WWQ2
HNGMNNIIRLFLKKG

HUWE1

2206

Q7Z6Z7
MNHQALVRKLPDLEK

BPNT2

341

Q9NX62
KANLHALIQMKPALS

RICTOR

781

Q6R327
ALIQMKPALSHLGDK

RICTOR

786

Q6R327
LGHQKKLMLGVKRLA

CASKIN2

606

Q8WXE0
LAALHLMASPKVNKD

NLRC5

521

Q86WI3
HFLKRDANKLQIMLQ

PACS1

181

Q6VY07
GSLKMNNIELHKQGL

MEI1

376

Q5TIA1
LKGALHRALQRKRSM

OR2A2

296

Q6IF42
KLIQDHMAKLQLNLR

KAT6A

751

Q92794
KLPDLRTLNNMHSEK

NR1D1

591

P20393
MQSLLLQRKASGLHE

PDP2

451

Q9P2J9
MLKSENLLGKQIDHL

ATM

1321

Q13315
LLQLSKMAINHTGEK

ATM

1651

Q13315
NCKLLEGLKLMNLEH

CHD9

1006

Q3L8U1
MNLRKTHILQKAPAL

CEP104

871

O60308
GNSVLLHISKLQMKD

CD101

101

Q93033
KLLSRHRNKNTMNGA

C2CD2

676

Q9Y426
QANIKNGKHLLMSIS

CHD6

1771

Q8TD26
HRDLKVSNLLMTDKG

CDK10

161

Q15131
NALLREQLEHMKKAN

CROCC2

171

H7BZ55
RMHSLLIKNLKNEIT

COPA

431

P53621
NVKLAQHALAGMQKL

ARFGEF3

61

Q5TH69
MARLVLKSKNGIHLR

CYP4A22

491

Q5TCH4
RALGITLMGHQKKIL

EPHA8

971

P29322
MSHSREKLLNALEKL

IFIT1B

411

Q5T764
MATLLLFKHQKLLGE

GPAT2

466

Q6NUI2
LHVVLKGSNNDMKVL

ZNHIT6

441

Q9NWK9
NRIKVMELLLKHGAS

ANK3

411

Q12955
ANLMKTLQHDKLVRL

LYN

291

P07948
HIRKLLQKMDRPNGL

MAN1A2

361

O60476
DVVTKKRLRNMLGHL

CDC20B

301

Q86Y33
QLLKVLGTRKLMHVA

DYNC1H1

391

Q14204
HLLLRRQTLAKAMDK

CYP4B1

31

P13584
KKMLNKVNLGHAART

EML5

1726

Q05BV3
QMRLSGKKHLLQELR

EVC

661

P57679
NALMHALTDLRKKNP

HLTF

836

Q14527
LAKKQLLMVRQAALH

CFAP141

61

Q5VU69
ALHLMQNLDTKSKLR

CRYBG1

766

Q9Y4K1
RQAKQIVSSAKMLLH

HELQ

1056

Q8TDG4
AQMELKKSLHGEARI

CCDC198

166

Q9NVL8
QKMLKNLKEGGHRVL

CHD4

1056

Q14839
HMPAALQDFLLLKQK

DHRS9

296

Q9BPW9
QLILKHMESRQKGLI

HSD17B3

166

P37058
LKELRKAAHRNGMKN

SLC22A25

296

Q6T423
TMGNLKQHLLTHRLK

SALL3

1016

Q9BXA9
LKTKMHSDNLLRNDL

PKNOX2

166

Q96KN3
RKNMAPQRKDLHGLS

CFAP74

1131

Q9C0B2
LKTSMIQHDKLNLGP

C18orf63

471

Q68DL7
VGQLMDGLKQLKLHR

ENPP2

336

Q13822
KFKAMQSNGILLHRE

CNTNAP3B

211

Q96NU0
LLARVDHLMKVGKNN

DIMT1

181

Q9UNQ2
KMHRDIKGANILLTD

MAP4K5

136

Q9Y4K4
ILLSILKMHSAKGRQ

OR5T3

251

Q8NGG3
QLSMLKKAHGLLAEE

NUMA1

1436

Q14980
LHGLQLKMSILQSRE

PHF20

756

Q9BVI0
QISSLQKLKHLNLGM

RSU1

81

Q15404
QKLKHLNLGMNRLNT

RSU1

86

Q15404
NQHLAMLAKKLELDR

DROSHA

1006

Q9NRR4
ALRHQTKIMFKNLLQ

THADA

406

Q6YHU6
LEDTKMNGHLRLLNI

RAPGEF6

506

Q8TEU7
KNIVHRDLKLGNMVL

STK40

191

Q8N2I9
RDLKLGNMVLNKRTH

STK40

196

Q8N2I9
DKEINSPNLLKMIRH

SOS2

811

Q07890
RKLILAGNIIHSLMK

SLITRK6

366

Q9H5Y7
LLTSHQNLLRMTKEK

SYNE1

2601

Q8NF91
NKEKLLMISRSHNNL

TMEM200A

456

Q86VY9
QSNIKHMRKQLDRLG

LARS2

151

Q15031
ENHIMSNLRQVGLKK

FILIP1

831

Q7Z7B0
QHTFLKNMGIDVRLK

NDUFAF7

356

Q7L592
HMLLNLSRGKQDFLK

RGPD2

356

P0DJD1
KARMKLTLLHRELQA

PTGIS

121

Q16647
FQMHRALAALKNKPL

FASTKD3

16

Q14CZ7
NARTKFHVLKMLLNL

GPRASP2

731

Q96D09
ALHLGSQLLRELKKM

PSMD11

146

O00231
QMSRLAKLTKAHRQG

PIK3C3

171

Q8NEB9
MQLALFQGIAKKHRA

PPWD1

401

Q96BP3
LDKALELNMLSLKGH

PSAT1

321

Q9Y617
QRLAHLNKCLMNFKL

PUS7

311

Q96PZ0
IHKDPEQLMNTLRKL

POLR2B

576

P30876
DNLKKLRMLDLRHNK

SHOC2

166

Q9UQ13
KNLMQLNLAHNILRK

PRELP

221

P51888
KDDFLHGLQMLKSLQ

POMK

116

Q9H5K3
VLGKKQEALRILQMH

SYCE1L

96

A8MT33
LVSKMLRAVLQSHKN

TDRD7

6

Q8NHU6
HKGLLELNQMRAFKS

L3HYPDH

286

Q96EM0
ILHRDMKPQNILLAK

STK36

121

Q9NRP7
INRKLSAAGMHEALK

HTR7

406

P34969
MKNLVLKLRASSHNL

CNK3/IPCEF1

81

G9CGD6
MKNLVLKLRASSHNL

CNKSR3

81

Q6P9H4
LGDNLMALNHADKLL

CNOT10

546

Q9H9A5
MALNHADKLLQQPKL

CNOT10

551

Q9H9A5
MRKNIKGIHTLLQNL

NTRK2

796

Q16620
LHMLQRKLGRKLNPE

SPATA4

216

Q8NEY3
LKDLEQLAKMLGHSA

RNF213

4621

Q63HN8
VLHKDKSLENLGMLR

TMTC4

251

Q5T4D3
LLFKQKSNGMHSLIA

TSR1

666

Q2NL82
KSLEHLRKQMQDALL

TRIM11

141

Q96F44
DQKLLLAGMHRNLAI

MIOS

196

Q9NXC5
QLLKLMSTVDPKLNH

SRSF11

186

Q05519
SQLLTLMDGLKQRAH

VCP

326

P55072
GRLEILQIHTKNMKL

VCP

376

P55072
TGLFELSQHMKLKLQ

TRAPPC14

461

Q8WVR3
KRIIHRDLKAGNVLM

STK10

151

O94804
PSRKIMLNLEGHKQE

FGD6

71

Q6ZV73
LLDMRIKHLIKTNQL

ZNF292

191

O60281
RHNLLQACKMQDIKL

SMC1A

926

Q14683
TGRMEKHLDALLKQI

STAG1

606

Q8WVM7
HRLAAKSLLQTKDMG

VWA5A

546

O00534
TGKENKVLLAMNLHN

WNT16

191

Q9UBV4
NSSPVINHLLLGKKM

TBC1D30

676

Q9Y2I9
GKLHTQPKLAAQLRM

VILL

371

O15195
PDNMLLDKSGHLKLA

ROCK1

201

Q13464
LHGRRNSGKLMSLDK

ZSWIM6

1121

Q9HCJ5
RHKLMSLIQKEAQGQ

XPNPEP3

76

Q9NQH7
KKLMHQAALLGQALC

TXNRD3

211

Q86VQ6
ILNGLHEEMLNLKKL

USP10

531

Q14694
HEEMLNLKKLLSPSN

USP10

536

Q14694
LRKLHGLEILNSTMK

TTC12

686

Q9H892
LFAQKRTMLEHLKNT

ZNF687

866

Q8N1G0
SLRPHKMKSLLGQNV

TRAPPC9

551

Q96Q05
LHLLEDLSIKNKQRM

YIPF7

11

Q8N8F6
MTDQVKLALNKHLLG

TRANK1

2116

O15050
RKMLHLRKQLLSLTN

TBK1

621

Q9UHD2
KLSLKNRILNHFGPM

LONRF3

686

Q496Y0